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Abstract
Healthcare is an essential part of life, but modern healthcare systems are faced
with many challenges. Costs and resource demand in healthcare facilities have
been steadily rising, largely due to the ever-increasing global population. Our
population is also older than ever, which in turn leads to increased prevalence of
chronic health conditions and higher pressure on healthcare systems.
Many chronically ill patients need to spend large amounts of time in hospital,
with a variety of manual or invasive monitoring techniques used to observe their
health. This places high strain on healthcare workers such as nurses and doctors,
and also places significant emotional and financial strain on patients and their
families.
This thesis explores machine learning (ML) solutions that stand to greatly
improve the standard of healthcare worldwide, beginning with methods of non-
invasive vital sign measurement that could be used at home or in healthcare
environments. Focus then turns towards better utilisation hospital resources
in the intensive care unit, by quantifying severity of illness through mortality
risk prediction in various windows and thus empowering healthcare workers to
effectively triage and make treatment decisions..
Non-invasive and continuous methods for measuring systolic and diastolic BP
using hybridized neural network from easily-obtained HR signals are explored,
with the aim of eliminating the need for invasive intra-arterial measuring or the
use of uncomfortable sphygmomanometers. Using raw HR signals obtained via
photoplethysmogram and electrocardiogram sensor as inputs, a hybrid convolu-
tional and long short-term memory (CNN-LSTM) neural network (NN) is shown
to perform strongly for the task, and meets the high industry standards for blood
pressure monitoring devices.
iii
A solution with fewer input features is also explored, with the aim of improv-
ing computational efficiency for low-powered devices. This scheme uses features
of the ECG and PPG waveforms rather than manually calculated features and a
smaller CNN-LSTM network. It is shown to perform comparably to the scheme
utilising raw waveforms as inputs despite the significantly reduced number of
features, and again meets industry standards.
The RR is commonly measured through manual counting of breaths, a te-
dious and time-consuming process. As such, the automatic and continuous mea-
surement of this parameter is investigated. Multiple respiratory variations are
extracted from HR signals, with each used to determine an estimate for RR. A
respiratory quality index (RQI) is also developed to determine the quality of the
respiratory variation signals. RR estimates and corresponding RQIs are used
as inputs to a bidirectional long short-term memory (BiLSTM) network. This
process was repeated for three different segment lengths - 20, 30, and 60 seconds.
In all three cases, the BiLSTM network performed significantly better when the
novel RQIs were included as features.
The second section of the thesis explores mortality risk prediction, beginning
with adult patients. In this work, it is shown that adult mortality risk in intensive
care units within short- and long-term windows can be reliably assessed using
hybrid CNN-LSTM networks and vital sign data. The easy-to-acquire features
also ensures that mortality risk can be continuously updated without manual
intervention, allowing healthcare staff to observe trends in how the patient is
responding to treatment.
Lastly, this work investigates the prediction of neonatal mortality risk. Pre-
mature babies are a high-risk group of patients, and quantifying their risk levels
can assist in treatment decisions. In this work, we show high prediction perfor-
mance for neonatal mortality using only gestational age, birth weight, RR and
HR data as input features to a CNN-LSTM network.
iv
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Chapter 1
Introduction
1.1 Background & Motivation
Healthcare is an essential part of life. Worryingly, modern healthcare systems
are under immense strain due to a growing and ageing population and a related
rise in chronic illness [6]. Resources from medical professionals to hospital beds
are in high demand across the healthcare sector [7].
Critical care is one of many healthcare services experiencing strain as a result
of an ageing population, with over 60% of admissions to Victorian Intensive
Care Units (ICUs) in 2010-11 occurring in patients over 60, despite this group
representing less than 20% of the population during this period [8].
ICUs treat the most critically ill of patients, and as such have the highest
mortality rate of all hospital units [9], ranging between 13.0%-14.4% in tertiary
hospitals in Victoria from 2001-2011 [8]. Patient outcomes are improved with a
high staff-to-patient ratio in ICUs [10], however providing this level of care comes
at a high cost. In 2013/14, intensive care in Australia cost $4,375 per patient
bed-day, resulting in an annual expenditure of $2,119 million dollars [11].
On the other end of the age range, Special Care Nurseries (SCNs) and Neona-
tal Intensive Care Units (NICUs) provide high levels of care to critically ill new-
borns. The rate of infant admission to SCNs and NICUs has been steadily
increasing, with 18.3% of all babies born in Australia admitted to one of these
critical care environments in 2018 [12]. As of 2018, the mortality rate for neonatal
patients was 2.2% [12].
While critical care for all age groups has undergone significant innovation and
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improvement in recent years, many issues remain. Some monitoring techniques
remain largely manual, with manual counting of breaths over a one-minute period
for respiratory rate measurement remaining the accepted method [13]. Such
manual measurement has been shown to be limited by factors such as patient
awareness, time constraints, external interruptions, and patient agitation [14–
16]. The time cost of patient monitoring is high, with nurses spending 7.2% of
their time performing patient assessment [17]. Other monitoring techniques in
critical care units are often invasive, such as gold-standard intra-arterial blood
pressure monitoring [18], which in turn leads to increased infection risk.
Treatments can also be highly invasive, with mechanical ventilation received
by 42% of ICU patients [8]. These invasive methods are only used where ab-
solutely necessary, however it can be challenging to make decisions about when
to initiate, alter, or withdraw such treatments. Recent studies have shown that
mortality risk assessment can aid in making difficult treatment decisions [19].
Decision making becomes increasingly important and no less challenging in
times of crisis. The ongoing COVID-19 pandemic has highlighted how rapidly
modern healthcare systems can be overwhelmed by widespread disease. Impacts
of the pandemic on ICUs and the wider healthcare system have been reported
across the world, in countries including Italy [20], France [21], Brazil [22], the
United Kingdom [23], the United States [24], and China [25]. Such impacts have
included overcrowding of hospitals [20], lack of resources [20, 23, 25], and in-
creased risk of infection among essential healthcare workers [23]. In Australia,
ICUs have identified their ability to add more beds, however the effectiveness of
this is restricted by a low capability to increase mechanical ventilation units and
staffing levels [26]. The widespread and significant impacts have lead to challeng-
ing decision making, with several reports examining ethical and fair rationing of
increasingly limited healthcare resources [27–29].
Mortality risk prediction could ease the burden of such decisions, allowing
healthcare workers to assess which patients require the most urgent access to
limited resources such as invasive ventilation. Unfortunately, existing methods
for quantifying mortality risk are limited in that they depend heavily upon labo-
ratory test results, are calculated once at admission and not updated throughout
Chapter 1 3
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the stay, and decline in performance over time [30, 31].
The burden of COVID-19 on healthcare systems has also had significant im-
pacts on out-of-hospital care. Following the 2020 outbreak of COVID-19 in
Lombardy, emergency services took longer on average to arrive at medical in-
cidents than in 2019. Additionally, occurrences of out-of-hospital death where
resuscitation was attempted increased by 14.9 percentage points [32]. Out-of-
hospital monitoring with non-invasive devices would improve at-home care and
allow for rapid detection of a medical emergency, and thus improve response
times. Such at-home monitoring would have ongoing benefits in routine health-
care beyond the pandemic, particularly for elderly, chronically ill, or otherwise
at-risk patients.
Improvements in monitoring would offer significant advantages to the health-
care system. The development of automatic, continuous, and non-invasive meth-
ods for measuring vital signs such as respiratory rate and blood pressure would
greatly enhance monitoring both at-home and in the hospital. Moving to non-
invasive methods of measurement would also reduce the high infection risks in
intensive care units, particularly for the at-risk populations of neonatal and el-
derly patients. For patients admitted to the hospital, and more seriously the ICU,
mortality risk monitoring is an essential tool for improving patient outcomes by
enabling informed decision making around treatments.
In recent years, machine learning has emerged as a technique for improving
healthcare in areas including vital sign monitoring [33–45], detection of clinical
events or deterioration [46–54], and mortality prediction [36, 55–63]. However,
much of the research to date is not yet suitable for clinical implementation.
Motivated by the challenges in healthcare monitoring both in and out of ICU
environments, there are two main objectives for this thesis. Firstly, this thesis
develops machine learning methods for continuous and non-invasive measurement
of respiratory rate and blood pressure, using data from sensors that are readily
available and highly wearable. Secondly, this thesis aims to improve patient
outcomes in the ICU and NICU by developing mortality risk assessment tools
that utilize machine learning to predict mortality outcomes from readily obtained
vital sign measurements and basic demographics. Overall, this thesis presents
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solutions for improved measurement and monitoring of patient health in a range
of settings.
1.2 Research Problems
This thesis focuses on improving healthcare through the use of machine learning
techniques in several areas. The research problems investigated include the de-
velopment of novel methods for monitoring blood pressure and respiratory rate
continuously and non-invasively, as well as the development of tools for quantify-
ing severity of illness using vital sign information in intensive care units. These
research problems are elaborated upon as follows.
1.2.1 Blood Pressure Monitoring
Blood pressure is an important health parameter that can provide much infor-
mation about a patient’s cardiovascular health. The current gold-standard for
blood pressure monitoring is invasive intra-arterial monitoring with a pressure
transducer inserted into a suitable artery. While this method is capable of con-
tinuous monitoring, it is invasive and can only be utilised in clinical settings.
Other methods, such as the use of cuff-based sphygmomanometers, cannot pro-
vide continuous measurements of the parameter and remain uncomfortable.
Continuous and non-invasive blood pressure monitoring would be an ideal
solution to this problem, and much research has looked to achieve this goal.
However, the research problem remains relatively new and existing schemes have
not yet succeeded in meeting the standards required for clinical implementation.
To address this problem, this thesis proposes two schemes - one focused on max-
imum performance and the other on finding a balance between performance and
computational efficiency - that utilise hybridized neural networks to determine
blood pressure from electrocardiogram and photoplethysmogram waveforms.
1.2.2 Respiratory Rate Monitoring
Respiratory rate is a key vital sign, however it has been historically under-
recorded. The primary reason for this is that the accepted method for mea-
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surement is manual counting of the breath over a one-minute period, which is
time-consuming for healthcare professionals. Other methods are obstructive and
uncomfortable for patients, requiring placement of devices over the mouth or
nose to accurately measure the parameter.
The development of a method for measurement of respiratory rate in a non-
invasive and continuous manner has long evaded researchers, with devices from
microphones to stretch sensors trialled for the purpose. Unfortunately, many
sensors are still obstructive and not suitable for long-term wear. Additionally,
sufficient performance has not been achieved in the literature to date. This thesis
addresses the research problem of accurately monitoring respiratory rate through
non-invasive techniques through the development of a scheme that extracts res-
piratory modulations of the electrocardiogram and photoplethysmogram wave-
forms and assesses their quality, using quality indices and candidate respiratory
rate values as inputs to a neural network for final prediction of respiratory rate.
1.2.3 Mortality Risk Assessment
Decision making regarding resource allocation in intensive care units is a chal-
lenging and yet essential task. This has become increasingly apparent throughout
the COVID-19 crisis, which has seen ICUs filled beyond their capacity and thus
left healthcare professionals to decide which patients should be allocated the lim-
ited numbers of life-saving equipment such as mechanical ventilators. This is an
emotionally challenging task and places high strain on healthcare workers.
Making decisions regarding treatment paths is also challenging in critical care
environments, and it is often difficult to determine whether a patient is improving
or deteriorating following certain treatment path. As such, it can be often be
hard to determine when to start or withdraw treatments.
Mortality risk assessment can ease decision making in both areas, however
existing schemes are limited by their dependencies on knowledge of medical his-
tories and extensive laboratory results. Additionally, the performance of existing
schemes has been shown to deteriorate with time. Finally, the complex nature
of existing schemes means that mortality risk is typically only calculated once at
the commencement of the stay, and not updated throughout.
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Mortality risk assessment has attracted much interest in the literature, par-
ticularly from researchers aiming to use machine learning to improve predictions.
While machine learning improves the calibration problem (as machine learning
models can continuously learn as they work), schemes in the literature remain
dependent on complex variables and are not continuously updated throughout
the stay.
This thesis aims to address these problems by developing a hybrid neural
network scheme for the measurement of mortality risk within 3, 7, and 14 days.
One model is proposed for adult patients, and another for neonatal patients. In
both models, only vital signs, age characteristics, and sex are used as features.
The simplicity of these variables ensures that the scheme can be continuously and
automatically updated throughout a patient’s stay to allow ongoing assessment
of their condition.
1.2.4 Summary
To summarise, this thesis addresses several key research problems: the continu-
ous and non-invasive measurement of both blood pressure and respiratory rate,
and the development of mortality risk assessment schemes for both adult and
infant patient groups. The development of techniques for improved vital sign
monitoring not only improves at-home healthcare monitoring, but also greatly
enhances the ability of mortality risk prediction schemes to provide accurate
results. Addressing these major research problems has lead to the original con-
tributions outlined in the following section.
1.3 Original Contributions
To address the research problems outlined in Section 1.2., the following original
contributions to the literature are presented in this thesis:
1. In chapter 3, a robust and powerful hybrid neural network for non-invasive
and continuous blood pressure measurement that uses raw waveforms from
wearable electrocardiogram and photoplethysmogram sensors as inputs is
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developed, and is shown to meet industry standards for blood pressure
devices.
2. In chapter 3, a low-power alternative neural network scheme for blood
pressure measurement using 12 features that describe the shape of the
electrocardiogram and photoplethysmogram waveforms is also presented,
showing little compromise on predictive performance compared to the raw
waveform scheme and a significant decrease in computational time.
3. In chapter 4, a machine learning scheme for continuous and automatic
respiratory rate measurement is designed, based on deriving respiratory
signals from modulations to photoplethysmogram and electrocardiogram
signals caused by respiration and conducting respiratory signal quality as-
sessment.
4. In chapter 5, a hybrid neural network is constructed to create an accu-
rate and continuously-updating scheme for mortality prediction in adult
intensive care units, utilizing only vital signs and basic demographics as
features.
5. In chapter 6, the work on adult mortality risk assessment is extended upon
to develop a mortality risk assessment scheme for neonatal patients admit-
ted to neonatal intensive care units, utilizing respiratory and heart activity
variations along with basic demographics as features.
1.4 Significance
This thesis fills significant gaps in the healthcare monitoring literature. The
techniques presented for measuring blood pressure (BP) and respiratory rate
(RR) outperform previous literature, offering a strong solution for non-invasive
and continuous measurement of these parameters in environments ranging from
the home to the hospital. The algorithms for both blood pressure and respiratory
rate are based on photoplethysmogram (PPG) and electrocardiogram (ECG)
signals, which are widely used in devices from fitness trackers to medical-grade
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hospital equipment. The sensors that record these signals are also non-invasive,
unobtrusive, and can be continuously recorded - unlike many existing alternatives
for measuring BP and RR. As such, the proposed algorithms for measuring BP
and RR could be utilized by health and fitness device manufacturers to develop
tools from fitness watches to non-invasive monitors for critical care environments.
Additionally, the mortality risk prediction schemes for adult and neonatal
patients are the first to show that mortality risk can be continuously and accu-
rately predicted using only vital signs and basic demographics, enabling ease-
of-use and reducing the burden of care on healthcare providers in intensive care
environments. As the algorithm only depends upon vital signs, it could be uti-
lized by medical device manufacturers to develop wearable devices for automatic
and continuous severity of illness assessment, both in hospital and in telehealth
applications. This would minimize and potentially eliminate the time cost asso-
ciated with currently used mortality risk assessment schemes, and would enable
at-home monitoring for high-risk patients. Additionally, it would be possible to
create an entirely non-invasive device for this purpose if the proposed schemes
for measuring BP and RR were implemented alongside established techniques for
non-invasively measuring the remaining vital signs, which would greatly improve
patient experience.
Overall, the algorithms presented in this thesis offer solutions for a wide range
of significant problems in the field of healthcare, with applications ranging from
fitness to telehealth to critical care.
1.5 Document Organization
The structure of this thesis is as follows. Chapter 2 presents a thorough review of
the literature, with focus placed on previous works in the areas of blood pressure
monitoring, respiratory rate measurement, and mortality risk assessment. Rele-
vant machine learning techniques are also discussed, with reference to previous
works in the healthcare field.
Chapters 3-6 are the research chapters, focused on addressing the research
problems outlined in Section 1.2 through achieving the objectives outlined in
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Section 1.3. The following figure provides an overview of the structure of the
research chapters, and the relationships between them.
Figure 1.1: Conceptual framework illustrating the relationship between research
problems
As Fig. 1.1 illustrates, Chapter 3 presents two machine learning methods
for estimation of blood pressure from photoplethysmogram and echocardiogram
waveform. The first scheme uses raw PPG and ECG waveforms as inputs to a hy-
brid neural network, while the second scheme improves computational efficiency
by selecting features that describe the shape of the waveform and using these as
inputs to a hybrid neural network. Respiratory rate measurement is considered
in Chapter 4, where a scheme for extracting respiratory signals from heart activ-
ity information is proposed. Each extracted respiratory signal is assessed using a
respiratory signal quality index, and machine learning is then utilized to predict
the respiratory rate based on multiple signals extracted from heart activity. The
development of these two schemes is strongly related, as they are the only two
vital signs that do not have an existing method for continuous and non-invasive
measurement. The same input signals are used for both works, allowing for the
two schemes to be integrated into a single device readily.
After developing schemes for measuring vital signs, this thesis then turns to
using vital sign information for enhanced prognostics tools in clinical settings. As
shown in Fig. 1.1, Chapter 5 proposes a scheme for predicting mortality using
basic demographics and statistics extracted from temporal vital signs. This
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scheme is able to be readily updated throughout the stay, allowing for ongoing
assessment of a patient’s health and response to treatments. Building upon this,
neonatal mortality risk assessment is then considered in Chapter 6, using only
heart rate and respiratory rate information along with basic demographics to
assess mortality risk in infants.
Following the research chapters, Chapter 7 concludes this thesis with several




This chapter presents a literature review of novel vital sign monitoring tech-
niques and machine learning in healthcare, with emphasis on four key aspects:
blood pressure measurement, respiratory rate measurement, and mortality risk
prediction for both adults and neonates in the intensive care unit.
An earlier version of this literature review has been published in the following
journal article:
[1] S. Baker, W. Xiang, and I. Atkinson, “Internet of Things for Smart
Healthcare: Technologies, Challenges, and Opportunities”, IEEE Access, vol. 5,
pp. 26521-26544, November 2017
2.1 Vital Sign Monitoring
Vital signs quantify the status of several fundamental life-sustaining functions
of the body. The four fundamental vital signs are heart rate (HR), body tem-
perature, respiratory rate (RR), and blood pressure (BP) [64]. The monitoring
of pulse rate is largely a solved problem, with wrist-based photoplethysmogram
(PPG) sensors considered most comfortable for a long-term wearable system [65].
The operation of these sensors is illustrated below, and involves an LED shining
light into the artery. Some light is absorbed by the blood, while the remainder
reflects back to a photodiode. The amount of absorbed light varies while the
heart beats, and as such heart activity waveforms can be extracted and used to
assess parameters such as HR and blood oxygen saturation. Such sensors have
already been widely implemented commercially, with many devices by brands
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including Fitbit, Apple, and Garmin validated in the literature [66–69] and used
for a variety of research projects [70].
Figure 2.1: Photoplethysmographic pulse sensor
Aside from PPG sensors, echocardiogram (ECG) sensors can also be used to
acquire information about heart health, including the vital sign of heart rate.
ECG measurements are typically performed in healthcare settings, with multiple
electrodes used to monitor the electrical activity of a patient’s heart. However,
recent research has shown that ECGs can be reduced to as few as one electrode,
therefore making them more suitable for implementation into wearables including
wrist bands and chest straps [71–73].
Another of the vital signs is body temperature, which can be used to detect
hypothermia, heat stroke, fevers, and more. Measurement of body tempera-
ture is also a largely solved problems, with recent works surrounding the topic
primarily focusing on thermistor-type sensors. In [74, 75], the common negative-
temperature-coefficient (NTC) type temperature sensors were used, while positive-
temperature-coefficient (PTC) sensors were considered in [76, 77]. In all studies,
the thermistors were shown to measure a suitable range of temperatures for
monitoring the human body, with acceptable levels of error. These small sensors
could readily be included in a wrist-wearable device alongside PPG and ECG
sensing capabilities.
The two vital signs that are currently missing from the wearable wrist-watch
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picture are blood pressure and respiratory rate. The measurement of these two
parameters has become the focus of much literature in recent years. In this
section, existing methods in the literature for measuring blood pressure and
respiratory are critically analysed.
2.1.1 Blood Pressure Measurement
Blood pressure (BP) is a key parameter for assessing patient health. Hyper-
tension, a condition where BP is elevated above 140 mmHg for systolic blood
pressure (SBP) or 90 mmHg for diastolic blood pressure (DBP) [78], is a leading
risk factor for developing cardiovascular disease (CVD). It is also one of the most
common chronic illnesses, affecting 32% of adult Australians. Of those affected,
68% had uncontrolled or unmanaged hypertension [79]. Complications resulting
from hypertension lead to 9.4 million deaths per year [80]. Treatment to re-
duce blood pressure reduces the patient’s risk of developing CVD [81], however
treatment cannot commence until the condition is diagnosed.
Significant diagnostic benefit is also seen with accurate and continuous mea-
surement of mean arterial pressure (MAP), which is quantified by the relationship
between SBP and DBP:
MAP =
SBP + (2×DBP )
3
(2.1)
MAP is a useful parameter for determining overall blood flow and thus the
level of organ perfusion. Lower values for MAP can indicate high mortality risk
conditions such as sceptic shock, as well as less critical but still serious conditions
including syncope [82]. Conversely, elevated MAP causes cardiovascular strain
and can lead to serious and potentially fatal CVDs including stroke [83].
BP is an extremely important parameter, however there are no commercially
available devices capable of measuring BP continuously and non-invasively. The
current gold-standard method for measuring BP continuously is intra-arterial
monitoring, a highly invasive procedure that involves inserting an arterial line
into a patient’s blood stream [18]. This procedure must be performed in a sterile
clinical environment and increases the risk of infection for the patient. Intra-
arterial monitoring is therefore unsuitable for long-term BP monitoring.
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Sphygmomanometers are a much more common method for measuring BP.
These non-invasive devices are based on an inflatable cuff that is manually or
automatically inflated beyond the expected SBP, causing blood flow to be cut
off. The cuff is then slowly deflated, and the pressure at which audible blood
flow sounds begin is the SBP. Pressure continues to be reduced, and then the
pressure at which the blood sounds cease is the DBP [84]. While non-invasive,
sphygmomanometers still cause significant discomfort and are even used to as-
sess pain sensitivity in research applications [85, 86]. There are also several
limitations of sphygmomanometers. Firstly, they cannot perform continuous BP
monitoring [87]. Regular measurements are possible using an ambulatory sphyg-
momanometer, which can automatically inflate and deflate at regular intervals
to take multiple measurements within a 24 hour period. However this is not
truly continuous, and is disruptive to daily activities and sleep, and thus is not
a sustainable long-term solution. Another issue is that vibrations in the arterial
wall, which can be caused by conditions such as arrhythmias, can compromise the
ability of a sphygmomanometer to accurately measure BP [84]. They also cannot
be used on people with several pre-existing conditions, such as lymphedema [88].
Factors including cuff size and arterial wall stiffness (which varies with age) can
also greatly affect the performance of sphygmomanometers [84].
With the limitations of existing devices, there is a strong need for new meth-
ods of measurement of blood pressure. Continuous, non-invasive, and comfort-
able tools for measuring blood pressure would greatly improve diagnostic ability
and patient quality of life. The majority of the literature focuses on using manu-
ally extracted features of the electrocardiogram (ECG) and photoplethysmogram
(PPG) signals to estimate BP using various mathematical approaches.
Several early studies [89–92] attempted to derive simple equations that could
be used to accurately measure BP, based on the well-known inverse relationship
between systolic BP and pulse transit time (PTT). PTT is the time that it takes
for the pulse to travel from the heart to another point, usually the radial artery
at the wrist. The early works focusing on this [89–92] each used a combination
of ECG and PPG sensors, then derived expressions that utilised PTT and a
variety of other parameters to estimate BP. Each of these works were limited
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by a need to frequently recalibrate the included parameters to obtain accurate
results. These problems arose even with the small patient samples, such as the
6 patients used to develop the model in [90] and 9 patients in [92].
As a result of the limitations around manually derived algorithms for BP
estimation, several recent works have turned their attention to machine learning
(ML) techniques for calculating BP. Some have considered ML to predict BP
using basic demographics and health parameters including age and body mass
index (BMI) [93] or using sphygmomanometers [94–96]. However, these methods
are non-continuous, and as such the majority of the literature instead focuses on
using ML to estimate BP from ECG and PPG signals [33, 34, 36–38, 97–100].
Several of these works [33, 38, 97] use the large Medical Information Mart for
Intensive Care (MIMIC-III) database, which includes over 40,000 patient records
from multiple critical care units in the period of 2001-2012. The aforementioned
works extracting features including pulse transit time (PTT) from the ECG and
PPG waveforms. These features were then used as the inputs to ML algorithms,
including AdaBoost in [33], multi-regression in [97], and multivariate adaptive
regression spline (MARS) analysis in [38]. While the MIMIC-III database is a
valuable resource, it suffers from intra-waveform alignment issues as the PPG
and ECG signals are not time-synchronised. This prevents accurate calculation
of PTT and other time difference features between the ECG and PPG wave-
forms [101]. As such, the schemes using MIMIC-III to obtain PTT and other
time-dependent parameters could not reliably be implemented in healthcare en-
vironments without further testing.
Two other recent works [37, 98] also used features including PTT extracted
from ECG and PPG signals, measured with the same equipment across all par-
ticipants. This likely improved consistency between measurements, however syn-
chronisation between devices measuring each waveform would remain challeng-
ing. The databases used in these works were small, with 85 patients and 110
patients considered by Miao et al. [98] and Song et al., respectively. Mean abso-
lute errors (MAEs) of 6.13 mmHg and 4.54 mmHg for SBP and DBP, respectively,
were achieved by the regression algorithm presented in [98]. Meanwhile, a MAE
of 4.8 mmHg was reported for both SBP and DBP by [37], achieved with a deep
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fully connected NN. These results are reasonable, however further validation of
the algorithms on larger patient databases would be required to confirm these
results.
The use of raw waveforms as input features is considered by [34] and [36].
In [34], regression algorithms including decision tree, support vector, adaptive
boosting, and random forest are trained to predict SBP, DBP, and MAP using
raw PPG waveforms. The adaptive boosting regressor performed the strongest,
achieving MAE values of 3.97 mmHg, 2.43 mmHg, and 2.61 mmHg, respectively.
However, the model shows signs of overfitting. The standard deviation (SD) is
high at 8.901, and 16% of all measurements had errors greater than 15 mmHg.
Raw ECG waveforms are used in [36] to train a regressor neural network (NN)
comprised of residual network and long short-term memory (LSTM) layers for
SBP, DBP, and MAP prediction. The MIMIC-III database was used along with
a second independent database, however synchronicity was not an issue given
that a single waveform was used with no timing-dependent features derived.
Results varied dramatically between databases, with the results on the MIMIC-
III database showing a MAE of 7.10 mmHg and SD of 9.99 mmHg for SBP, along
with a MAE of 4.61 mmHg and SD of 6.29 mmHg for DBP.
Several other works have investigated NNs for the prediction of BP, including
long short-term memory (LSTM) networks. However, the works that investigated
these used limited databases of 26 patients [100] and 96 patients [99], respectively.
Each work used manually extracted features of the ECG and PPG waveforms
as features. Minimal statistics were cited by each paper, with [100] citing root
mean square errors (RMSEs) of 2.571 mmHg and 1.604 mmHg for SBP and DBP,
respectively, while [99] reported RMSE values of 3.90 mmHg and 2.66 mmHg for
SBP and DBP, respectively. These values show promise for LSTM networks,
but significant further validation on larger databases and with more rigorous
statistical analysis is clearly required.
Aside from densely-connected and LSTM NNs, another candidate for BP
estimation is found in convolutional neural networks (CNNs). These networks
are well-known for their high performance in computer vision tasks, and raw
PPG and ECG waveforms could be effectively considered as images. They have
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previously been used to analyse ECG signals to detect conditions including atrial
fibrillation [51–53], however to the best of the author’s knowledge they have not
been used for BP detection from such waveforms.
The results of both [34] and [36] indicate that raw waveforms can be used
to predict BP with some success, however are not yet sufficient for clinical use.
Meanwhile, limited studies on small databases have suggested that NNs may
be suitable for analysing ECG and PPG signals, however there have been no
attempts to use NNs to analyse both waveforms simultaneously for the estimation
of SBP, DBP, and MAP. These are significant gaps in the literature.
In terms of assessing the performance of BP measuring algorithms and de-
vices, the most common technique in the literature is comparison to the Asso-
ciation for the Advancement of Medical Instrumentation (AAMI) standard and
British Hypertension Society (BHS) protocol for assessment of BP devices, each
of which is used for the validation of devices used in clinical applications. The
AAMI standard [102] is a pass-or-fail test that states that a device must be
tested on ≥ 85 people, achieve a mean absolute error (MAE) of ≤ 5 mmHg and
standard deviation (SD) of ≤ 8 mmHg compared to a gold-standard method to
pass, otherwise the device fails. Meanwhile, the BHS protocol [103] assigns a
grade between A-D depending on how many measurements have errors less than
several thresholds when compared to a gold-standard method. Only devices
that achieve ‘A’ or ‘B’ grades are recommended for clinical use. The criteria for
reaching different grades under the BHS protocol is outlined in Table 2.1 below.
Table 2.1: Grading criteria defined by the BHS protocol.
Absolute Difference (mmHg)
Grade ≤5 ≤10 ≤15
A 60% 85% 95%
B 50% 75% 90%
C 40% 65% 80%
D Worse than C
In terms of these two standards, none of the aforementioned works have
achieved ‘pass’ grades for the AAMI standard and ‘A’ grades for the BHS stan-
dard across SBP, DBP, and MAP. As such, it is unlikely that any of these schemes
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are suitable for clinical use. Thus, developing an algorithm that meets the re-
quirements set by the AAMI and the BHS remains a significant gap in the liter-
ature.
2.1.2 Respiratory Rate Measurement
Another of the vital signs is respiratory rate (RR), or the number of breaths
a patient takes per minute. Respiratory rate abnormality is one of the earliest
indicators of critical illness. Elevated RR has been linked to clinical deterioration
after emergency department discharge [104], cardiac arrest [105], pneumonia in
children [13, 14] and general mortality risk [106]. Meanwhile, fluctuations in RR
have been found to be strongly linked with patient stability [107].
Despite the importance of RR, it has been historically under-recorded com-
pared to other vital signs [15, 104, 108, 109]. One study has found that nurses do
not measure RR in 50% of cases due to time constraints and lack of equipment
[15].
In terms of equipment, the most common tools used for automatic RR mea-
surement are oronasal systems comprised of capnography, temperature, or mois-
ture sensors, however these have not been widely adopted [108].
Manual measurement through counting the number of breaths a patient takes
over a one-minute period remains the accepted method for determining RR [15].
This method has the obvious limitation of being non-continuous, however manual
measurement can also be negatively impacted by patient awareness, time con-
straints, interruption, and patient agitation [14–16, 110]. The need for manual
measurement of respiratory rate is also time consuming, with one study finding
that nurses spent up to 7.2% of their time on manual patient assessment [17].
Due to the diagnostic importance of RR and the major limitations in existing
methods of measuring this vital sign, many previous works have investigated a
variety of sensors and devices for measuring respiratory rate, including thermis-
tors [111], microphones [112], fibre optic vibration sensor [113], pressure sensors,
stretch sensors [74, 114, 115]. Each of these sensors has shown promise, however
they are not highly wearable. Thermistor-based devices involve sensor placement
in the nose, while the other sensor types are typically chest-worn.
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An emerging candidate for wearable RR measurement is the extraction of
respiration signals from PPG and ECG signals. There is significant movement
associated with breathing, along with changes in intrathoracic pressure. This
results in respiration modulating heart activity signals in three main ways -
baseline wander (BW), amplitude modulation (AM), and respiratory sinus ar-
rhythmia (RSA) modulation [116]. The extraction of these modulations and
subsequent use in estimating RR has been considered in several recent works
[39, 40, 42, 43, 117], with mixed success. Machine learning techniques including
linear regression and support vector regression have been considered [43], but
this has not been explored broadly on large datasets.
Overall, there are still substantial improvements to be made in the field of
measuring RR automatically and continuously. The most promising method is
the extraction of respiration modulations from the ECG and PPG signal. Ma-
chine learning has shown some promise on smaller datasets, however its potential
has not been widely explored for this purpose.
2.1.3 Summary
Blood pressure and respiratory rate remain the two most challenging vital signs to
measure, particularly in a continuous and non-invasive manner. Recent literature
suggests that the heart activity signals of ECG and PPG contain information
that can be used to calculate both BP and RR, however existing literature has
not yet met the standards required for clinical use. Machine learning techniques
have been explored to improve BP and RR estimation from ECG and PPG
signals, but this has not yet led to clinically-suitable devices.
2.2 Mortality Risk Assessment
The automatic and continuous measurement of vital signs can support a wide
variety of healthcare applications, including the assessment of mortality risk in
critical care environments. Intensive care units (ICUs) treat the most critically
ill patients and have the highest mortality rate of all hospital units [9], ranging
between 11.3-12.6% [118]. Mortality risk assessment can aid healthcare pro-
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fessionals in making treatment decisions and determining the effectiveness of
treatments [19].
Assessment of mortality risk has been considered in the literature for two main
age ranges: adults and neonates. In this section, the literature on mortality risk
assessment for adult and neonatal patients is thoroughly examined.
2.2.1 Adult Mortality Risk Assessment
Several points-based schemes are currently used in adult ICUs to quantify mor-
tality risk. The most prevalent of these are the Acute Physiology and Chronic
Health Evaluation (APACHE) score [119], Simplified Acute Physiology Score
(SAPS) [120] and the Sequential Organ Failure Assessment (SOFA) score [121].
APACHE and SAPS have each undergone several updates, with the most recent
versions being APACHE-IV and SAPS-III, respectively. Despite this, APACHE-
II and SAPS-II remain the most commonly used versions of these schemes world-
wide [122].
These scores rely on health parameters that are often time-consuming and
difficult to obtain, as well as manual data entry. In addition to these disadvan-
tages, it has been found that the performance of these schemes decrease fairly
rapidly over time, with SAPS-II found to be out of calibration within 12 years
of its development [30]. Several recent studies have also found calibration issues
with APACHE, SAPS, and SOFA [123–125]. Changing patient population and
medical treatments account for much of the calibration loss, as each of these
schemes is trained on a singular dataset at a particular point in time [30]. It
has also been observed that the schemes perform poorly on cohorts from differ-
ent regions than those they were trained on, including Europe and Singapore
[123, 125]. This indicates that insufficient consideration of diverse populations
affects the performance of the schemes.
The limitations of traditional scoring systems has lead to a rise in researchers
investigating machine learning for mortality prediction [35, 55–61] and related
applications including detecting sepsis risk [46–48, 126] and general clinical dete-
rioration [49, 50]. Techniques used included random forest [35], logistic regression
[55], gradient boosting [55, 59, 60], and neural networks [56–58, 61]. These recent
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works have focused on using machine learning techniques for binary classification;
that is, determining whether a patient is a mortality risk or not. Neural networks
were the most commonly used, and showed strong performance on smaller num-
bers of variables than was achieved with other techniques. Neural networks also
offer the benefit of being reasonably easy to configure for continuous learning,
ensuring that calibration is always up-to-date. This in turn leads to enhanced
ability to generalise to current populations, even as populations, treatments, and
outcomes change with time.
Most recent works [35, 56–60] have developed schemes that are heavily depen-
dent on laboratory results including those obtained from extensive blood, urine,
breath, and other clinical analyses. These parameters are often complex and
time-consuming to obtain, and then additionally require entry into the patient’s
medical records for the scores to be calculated.
Performance of mortality risk assessment schemes is typically quantified using
the area under the receiver-operator curve (AUROC), which compares the false-
positive rate (percentage of incorrect predictions of mortality) with the true-
positive rate (percentage of correct predictions of mortality) for a varying cut-off
threshold for mortality prediction. AUROC can range from 0-1. In terms of
this parameter, the highest performing of the aforementioned schemes was that
presented in with an AUROC of 0.94, however the scheme depended on other
scoring schemes including the All Patients Refined Diagnosis Related Groups
(APR-DRG) and Medicare Diagnosis Risk Groups (MS-DRG). The grouping
of patients under these schemes is dependent on doctor diagnosis, introducing
a significant human bias. APR-DRG and MS-DRG are also not used in all
hospitals, limiting the broader usage.
Another strong work was that presented in [59], achieving an AUROC of
0.927. However, this scheme depended on 148 features comprised predominantly
of complex laboratory results. The high number of parameters required would
place significant burden on healthcare workers in terms of measurement and data
entry, limiting the practical usefulness of the scheme.
Other schemes have attempted to use fewer variables, such as the scheme
presented in [55] which investigated the use of only vital signs as parameters.
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However, an AUROC of only 0.65 was achieved. Through expanding their vital
sign feature vector to include Glasgow Coma Score (GCS) and SAPS-II score,
they were able to raise the AUROC to 0.84 - however this again introduces
dependency on complex parameters. Nonetheless, this work showed promise for
the use of vital signs in predicting mortality risk. Another work to identify
the importance of vital signs in critical care was that presented in [126], which
found that 10 of the 20 most important parameters for detecting onset of septic
shock were derived from vital signs. Further exploration of the use of vital signs
in predicting mortality should be considered given that they measure the most
critical functions of the human body [127].
Another trend in the literature is the assessment of mortality risk for the
entire stay using data acquired at admission. However, one recent work [61] has
identified that this is inflexible given that a patient’s condition can dramatically
change during the stay, and investigated the use of a shifting window to iden-
tify mortality risk at any time. However, this scheme depended on 48 hours of
extensive laboratory values that would be time-consuming and difficult to con-
tinuously update. Further exploration of repeatable mortality risk prediction
would undoubtedly be valuable for assessing patient response to treatments and
detecting any deterioration.
While machine learning has been broadly explored in the literature, relatively
little research has investigated the use of neural networks (NNs) for mortality
prediction. Early works investigating NNs focused on simple feed-forward net-
works and achieved comparable results to traditional scoring schemes [128–130].
More recent works have identified long short-term memory (LSTM) networks
as candidates for mortality prediction [56, 61, 131], as have hybrid networks
comprised of convolutional neural network (CNN) and LSTM layers [57].
Overall, the major limitations in current mortality risk assessment schemes
for adult patients are the use of extensive and complex features, and the focus
on predicting mortality for the entire stay using data taken at and immediately
after the time of admission. Further investigation into developing a mortality
scheme that is able to be continuously recalculated throughout the stay with
simple features is required, and the use of NNs is a promising avenue to achieve
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this goal.
2.2.2 Neonatal Mortality Risk Assessment
Complications resulting from preterm birth are the leading cause of death in
children under 5 [132], causing over 1.1 million deaths per year globally [133].
Preterm infants are often admitted to Neonatal Intensive Care Units (NICUs).
As many as 84.41% of infants with birthweight between 500g-1499 g are admitted
to NICU in the United States, while 48.17% of infants weighing 1500-2499 g are
admitted.
Several scoring schemes comparable to APACHE and SAPS are used in the
NICU for mortality risk assessment. One common scheme is the Clinical Risk
Index for Babies (CRIB-II) [134], a simpified version of the earlier CRIB score
[135]. The Score for Neonatal Acute Physiology (SNAP) [136] and SNAP Perina-
tal Expansion (SNAPPE) [137] are also commonly used, as are their successors
SNAP-II and SNAPPE-II. Other scores such as the Berlin score [138] and Neona-
tal Mortality Prognostic Index (NMPI) [139] are also in use to a lesser extent.
The limitations of these scores are comparable to the limitations of the
APACHE, SOFA, and SAPS scores for adult mortality prediction. Each of the
scores for predicting mortality risk in neonates was developed over fifteen years
ago, with the publication of CRIB-II in 2003 marking it as the most recent
scheme. Recent works have identified a significant decrease in performance for
scores in the SNAP/SNAPPE family of scores [140] and CRIB-II [19]. A recent
extensive review of multiple scoring schemes [31] concluded that updated and en-
hanced scoring systems are required to account for the significant advancements
in neonatal care.
In addition to calibration loss, several scoring schemes feature complexity or
inflexibility in the variables used. CRIB-II is the simplest scoring scheme, relying
on five variables, however each of these are not updated after admission, limiting
the usefulness in determining patient response to treatment. Meanwhile SNAP-
II, SNAPPE-II, Berlin score, and NMPI each use complex variables including
PO2/FiO2, serum pH, presence of seizures, urine output, base excess, and more.
Due to the limitations of existing scores, several recent works have investi-
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gated alternative methods for predicting neonatal mortality risk. Studies have
investigated logistic regression [141, 142], densely-connected neural networks [63],
random forest [143], and fusion of multiple algorithms into a so-called “super-
learner” [62] for binary classification of mortality risk in neonates. Of these
schemes, the highest performing were those based on neural network techniques
[62, 63] and random forest [143].
While the use of machine learning can aid in overcoming calibration issues,
the works in the literature remain limited by the selection of variables that are
challenging to measure regularly. Parameters considered by the schemes in the
literature include laboratory results [62], maternal characteristics [63, 141], exist-
ing conditions [62, 63], and more. Other parameters are challenging to quantify
definitively, such as the condition of the baby through visual inspection used in
[141]. The use of such parameters increases burden on healthcare workers and
thus limits the usefulness of the scheme.
On the other hand, several works in the literature are limited by their se-
lection of variables that do not change, including pre-birth and start-of-labour
characteristics [141], blood oxygen at admission [142], and respiratory support
within the first 24 hours after birth [142]. Fixed variables prevent recalculation
of risk during the stay, thus preventing assessment of response to treatment and
other changes to the infant’s condition throughout their stay.
Given the similarities between adult and neonatal mortality risk prediction,
neural networks including CNNs and LSTMs are also strong candidates for as-
sessment of mortality risk prediction in infants. An ideal scheme would include
variables that are easy to calculate regularly, utilising a machine learning strategy
that would ensure calibration remains strong throughout the future.
2.2.3 Summary
Mortality risk prediction is an essential component of ICU decision making. Ac-
curate prediction of this parameter enables treatment decisions, resource alloca-
tion, and assessment of patient condition. However, existing schemes are limited
by the use of complex or fixed variables to quantify mortality risk. They are
further limited by their assessment at the start of the stay, without further up-
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dates during the stay to enable constant reassessment of the patient’s condition.
There are indications in the literature that machine learning techniques may be
suitable for mortality risk prediction, however schemes that have attempted the
use of machine learning have remained dependent on a high number of complex
input variables. There remains a significant gap in the literature regarding the
use of machine learning on non-complex variables that can be readily assessed
throughout the stay to enable continuously updating mortality risk assessment.
2.3 Neural Networks
Machine learning has been identified as a candidate solution for blood pressure
measurement [33, 34, 36–38, 93–100], respiratory rate measurement [43, 144], and
mortality risk assessment in both neonatal [62, 63, 141–143] and adult [35, 55–
61, 131] patient cohorts. Recently, several works in these healthcare applications
have focused on neural networks specifically [34, 36, 56, 57, 61–63, 99, 100, 131]
due to their enhanced ability to learn complex patterns compared to traditional
machine learning techniques such as logistic regression and random forest. As
such, this thesis has placed focus on neural network techniques for healthcare
applications.
Every neural network shares some core components. Firstly, neural networks
are comprised of three layer types: input, hidden, and output layers. The input
layer receives the features, the hidden layers are where the inputs are processed,
and the output layer returns the result of the operation. Within each layer there
are a number of units (also called cells or neurons) that perform a mathematical
operation. They each have their own weights and biases that are updated through
the process of training using an optimization algorithm. It is this process that
allows the network to learn from the data it is seeing. Units within the hidden
layers are typically called hidden units. In training a neural network, a loss
function is used to tell the network which parameter it is aiming to optimize (for
example, error or accuracy).
While neural networks have these characteristics in common, there are also
many differences across the various types of neural networks. In this section,
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several fundamental neural network structures are introduced and described in
detail.
2.3.1 Feed-Forward Neural Networks
Feed-forward neural networks (FFNNs) are also known as densely-connected,
fully-connected, or dense NNs. FFNNs are the most basic form of NN, with each
cell in a hidden layer connected to every cell from the previous layer. The major
advantage of FFNNs is that they are mathematically simple and therefore highly
efficient for small feature vectors. In many cases, if a FFNN were to perform
well, there would be little need for more complex NNs to be utilized. However,
works utilizing FFNNs for applications such as mortality prediction [128–130]
saw little improvement compared to manually-derived scoring systems. A single
layer of a FFNN can be mathematically described as follows:
yi = g(xi • wy + by) (2.2)
where yi and xi represent the output and input of layer i respectively, while wy
and by are the weights and biases, learned using the powerful Adam optimizer.
The symbol ‘•’ denotes element-wise matrix multiplication, and g() represents
the activation function chosen. There are several common activation functions,
including ReLU (g(z) = max(0, z)), sigmoid (g(z) = 1
1+e-z
), and tanh (g(z) =
tanh(z)).
An example of a FFNN with an input layer, three hidden layers, and output
layer is shown in Figure 2.2 below.
Aside from multi-layer FFNNs, it is common for a singular densely-connected
layer to be used as the output layer of other neural network types. This will be
illustrated in the following subsections.
2.3.2 Convolutional Neural Networks
Convolutional Neural Networks (CNNs) are broadly used in image and video
recognition tasks due to their ability to identify patterns. They have found use
in healthcare applications for tasks related to blood pressure and respiratory
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Figure 2.2: Example of a FFNN with three hidden layers.
rate measurement, such as recognizing variation in Korotkoff sounds [54] and
detecting heart abnormalities in ECG signals [51–53]. They have also been con-
sidered in combination with other network types for mortality risk assessment
[57]. Typically, they are most useful in applications where there are a large num-
ber of input variables and patterns are not already known. A single CNN layer






i ∗ xm(i-1) + bji) (2.3)
where yij is the output jth feature map of the ith layer, after convolution has been
performed and passed through the activation function. The symbol ∗ represents
the convolution operation. The parameter wjn
i is the nth weight of the jth feature
map from the previous layer, where n = 1, ..., N . The term xm
(i-1) represents the
outputs of the previous (i − 1)th layer, and lastly bj is the jth bias term of the
lth layer.
CNNs can be implemented for one-dimensional, two-dimensional, or three-
dimensional data. Time-series data, such as ECG and PPG signals, are examples
of one-dimensional inputs. An example of a CNN with three hidden units and a
densely-connected output layer is illustrated in Fig. 2.3.
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Figure 2.3: Example of a CNN with three hidden layers.
2.3.3 Recurrent Neural Networks
Recurrent Neural Networks (RNNs) are largely used for sequential data based on
their enhanced ability to ‘remember’ what they have learned in the past. This
makes the suitable for tasks such as handwriting recognition and language pro-
cessing. A traditional RNN is mathematically expressed through two equations.
Firstly, the equation that defines the activation value from time step t, with the
activation function denoted by g, is as follows:
at = g(waaa(t− 1) + waxxt + ba) (2.4)
where at is the activation value from time-step t that will is inputted to the
following time-step t+ 1 and a(t-1) is the activation value from time-step (t− 1),
providing information about the past. The parameter xt is the input for time-
step t, and ba are the relevant biases for calculating the activation value. waa
and wax are the weights for the activation value a(t-1) and input xt respectively.
The second relevant equation for RNNs gives the predicted output, and can
be defined as follows:
yt = g(wyaat + by) (2.5)
where yt is the output of layer t, at is the activation value of layer t, and wya
and by are the weights and biases used for calculating the output prediction,
respectively. The activation function is again denoted by g()
A graphical example of an RNN with three hidden layers followed by a
densely-connected output layer is illustrated in Figure 2.4.
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Figure 2.4: Example of an RNN with three hidden layers.
2.3.4 Long Short-Term Memory Networks
Long Short-Term Memory (LSTM) networks are an advanced type of recurrent
neural network, offering several additional benefits over simple RNN. LSTM
introduces several gates that make decisions regarding what to remember and
what to forget. LSTMs have been widely used in healthcare applications for tasks
such as predicting sceptic shock [145], seizure detection [146], cancer prediction
[147], heart anomaly detection [148] and blood pressure estimation [99, 100].
The following series of equations represent the process for updating the cell
state ct in a single layer t of an LSTM network. Activation functions are again
represented by g(), however activation functions used often vary for the gate
equations and final output equation.
c̃t = tanh(wc[ a(t-1), xt] + bc) (2.6)
f t = g(wf[ a(t-1), xt] + bf) (2.7)
ut = g(wu[ a(t-1), xt] + bu) (2.8)
ot = g(wo[ a(t-1), xt] + bo) (2.9)
ct = ut • c̃t + f t • c(t-1) (2.10)
at = ot • g(ct) (2.11)
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Eqn. (2.6) represents the calculation of candidate values c̃t that may be used
to update the cell state ct. Then, (2.7)-(2.9) show the calculation of the forget
gate f t, update gate ut and output gate ot respectively. Finally, the cell state
ct is updated in (2.10), while the layer output is determined in (2.11). The ‘•’
symbol in (2.10) and (2.11) represents element-wise matrix multiplication.
In (2.6)-(2.9), wc, wf, wu and wo refer to the learned weights for their respec-
tive operations, while bc, bf, bu and bo are the learned biases. Additionally, the
parameter a(t-1) refers to the output of the previous layer, while xt is the input
for time-step t. Eqn. (2.10) utilizes the results of (2.6)-(2.8) as well as the cell
state of the previous time step, c(t-1) to update the cell state, and (2.11) uses the
resultant cc as well as the output gate results.
An example of a LSTM NN with three hidden layers and a densely-connected
output layer is illustrated in Fig 2.5.
Figure 2.5: Example of an LSTM NN with three hidden layers.
A variation on LSTM is Bidirectional LSTM (BiLSTM). The LSTM network
described above feeds data through the network from beginning to end of the
sequence. BiLSTM also does this, but additionally passes the data through the
network in reversed order. Results of both forward and reversed passes are then
concatenated after each layer before being passed to the next layer. This enables
the network to learn from both past and future data. BiLSTMs follow the same
mathematical structure as unidirectional LSTM, applying this structure to both
passes of the data.
An example of a BiLSTM network is illustrated in Fig. 2.6. A single bidirec-
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tional layer is comprised of both forward and backward LSTM pass, as well as
the concatenation operation that combines them.
Figure 2.6: An example of a BiLSTM NN with three hidden layers.
2.3.5 Summary
In this section, several NN structures that have been previously used in the lit-
erature for healthcare applications have been presented. FFNNs are the most
mathematically simple of these, however have found limited success in health-
care applications previously. Despite this, a fully-connected output layer is a
standard feature of most NN structures. CNNs are strong contenders for large
feature vectors due to their ability to recognize previously unknown patterns,
while LSTM NNs have been found to perform strongly on sequential data. The
use and hybridization of these networks could provide substantial value to the
applications of blood pressure measurement, respiratory rate measurement, and
mortality risk prediction
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2.4 Conclusion
This literature review has conducted a comprehensive analysis of existing works
and technologies for monitoring vital signs and overall severity of illness. Through
this analysis, several key research gaps have been identified.
Firstly, there is no known scheme for non-invasive and continuous blood pres-
sure measurement that meets the key industry standards outlined by the British
Hypertension Society and the Association for the Advancement of Medical In-
strumentation. This indicates that existing schemes would not be suitable for
clinical implementation, leaving a substantial gap in the literature.
A similar issue is seen with respiratory rate measurement. Existing methods
are either manual or obstructive and uncomfortable. Several pilot studies have
considered non-invasive methods for continuous respiratory rate measurement,
however low error has not been achieved on large datasets. A significant research
gap remains in developing a robust technique for automatic, continuous and non-
invasive respiratory rate measurement that is highly accurate.
Currently, blood pressure and respiratory rate are the only vital signs that
cannot be measured continuously and non-invasively in clinical settings. The
development of schemes that fill these gaps would strongly support the develop-
ment of enhanced diagnostics and prognostics tools, including those for mortality
risk assessment.
In terms of assessing severity of illness or mortality risk in critical care pa-
tients, existing schemes suffer from a wide range of issues including time cost,
complexity of variables, and poor accuracy. The development of an easy-to-
interpret scheme based on parameters that can be automatically recorded would
fill a substantial gap in the literature.
This thesis addresses these significant research gaps, providing a broad range
of techniques designed for implementation in environments ranging from health
trackers to critical care units.
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Deep Learning for Blood Pressure
Estimation using Electrocardiogram
and Photoplethysmogram Data
This chapter contains materials published in the following article, which has been
accepted for publication with Computer Methods and Programs in Biomedicine:
[4] S. Baker, W. Xiang, and I. Atkinson, “A Hybrid Neural Network for
Continuous and Non-Invasive Estimation of Blood Pressure from Raw Electro-
cardiogram and Photoplethysmogram Waveforms,” accepted by Computer Meth-
ods and Programs in Biomedicine in May 2021.
This chapter also contains materials from the following manuscript:
[149] S. Baker, W. Xiang, and I. Atkinson, “A Computationally Efficient
CNN-LSTM Network for Estimation of Blood Pressure,” manuscript prepared,
publication to be pursued following the acceptance of [4].
3.1 Introduction
Blood pressure (BP) is a key diagnostic tool for a variety of life-threatening con-
ditions. Elevated BP, or hypertension, is a major risk factor for cardiovascular
disease (CVD), contributing to the deaths of 9.4 million people every year [80].
Additionally, poor organ perfusion can be identified through the measurement
of BP-derived parameters, particularly mean arterial pressure (MAP). MAP is
useful in determining overall blood flow and thus the level of nutrient delivery
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to organs, and therefore is routinely measured when dealing with high-mortality
conditions like septic shock [82]. MAP that is too low can lead to shock, syn-
cope, and poor perfusion to organs, while elevated MAP places strain on the
cardiovascular system and can eventually to various CVDs including stroke [83].
Despite the importance of monitoring BP, there are currently no commer-
cially available devices capable of continuous and non-invasive BP measurement
that have been approved for medical use. Currently, the gold-standard method
for continuous and accurate BP monitoring is intra-arterial monitoring, which
involves the invasive insertion of a catheter equipped with a pressure transducer
into a patient’s artery [18]. This is clearly not suitable for long-term monitoring
as it must be performed in a clinical environment and it increases infection risk
for the patient. Typically, BP is measured using less invasive sphygmomanome-
ters, cuff-based devices which is manually or automatically inflated to determine
BP. However, sphygmomanometers are incapable of continuous monitoring and
cause significant discomfort to many patients [87]. They also cannot be used on
people with several pre-existing conditions, such as lymphedema [88].
There is a clear need for improved methods of clinical and at-home BP mon-
itoring, especially for high-risk patients. As such, many recent works have in-
vestigated methods for non-invasive measurement of BP. One promising area of
research lies in machine learning (ML). ML techniques have been used to esti-
mate BP from various health factors such as age and gender [93], as well as for
improving sphygmomanometer measurements [95, 96].
More recently, many researchers have investigated the calculation of BP from
electrocardiogram (ECG) and photoplethysmogram (PPG) signals [33, 34, 36–
38, 97–100]. In [33, 38, 97], the Medical Information Mart for Intensive Care
III (MIMIC-III) database was used to obtain features such as pulse transit
time (PTT) and other manually extracted features of the ECG and PPG wave-
forms. These were then used with algorithms including AdaBoost in [33], multi-
regression in [97] and multivariate adaptive regression spline (MARS) analysis
in [38]. Unfortunately, the MIMIC-III database used by these works suffers from
intra-waveform alignment issues that make calculation of PTT and other time-
dependent features between ECG and PPG signals unreliable [101]. As such,
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these schemes could not be reliably applied in healthcare applications.
In [34], raw PPG waveforms are used to train an AdaBoostR algorithm to
estimate SBP, DBP and MAP. This model was trained on a small subset of the
MIMIC-II data of 1,323 records and not validated on a distinct testing set. In
results presented from the training set, the model was clearly suffering from a
large number of high-range errors and large standard deviation (SD), particularly
in SBP estimation. This indicates that the model had overfit to the training data,
and therefore would be unlikely to perform strongly on new data.
Meanwhile, in the recent paper [36], raw ECG waveforms are used to train
a neural network for SBP, DBP, and MAP prediction. Testing was performed
on MIMIC-III data, as well as a second independent database. Results across
these two databases varied significantly, with the scheme shown to not perform
as strongly on the large MIMIC-III database. It is likely that utilizing both PPG
and ECG data would significantly improve performance, and PPG signals are
comparatively easy to obtain from wearable devices compared to ECG signals.
Two recent works [37, 98] obtained features from ECG and PPG signals before
using ML techniques to predict BP. Features considered included PTT, which was
measured using the same equipment across all participants. This likely improved
synchronization between devices when compared to the waveform synchronity
issues in [33, 97, 150], however clock drift could still impair PTT calculation over
longer periods. Each of these works built small databases using measurements
from healthy volunteers, with [98] obtaining readings from 85 patients and [37]
using 20-second segments from 110 subjects. Good results were presented in both
works, however larger databases would be needed to verify that these schemes
would perform well on a wide range of patients.
In this chapter, two hybrid neural network (NN) schemes are proposed.
Each scheme incorporate temporal convolutional neural network (CNN) and long
short-term memory (LSTM) layers for the estimation of BP. In each hybrid NN,
he CNN layers act to identify the most important features, while the LSTM lay-
ers have a strong ability to remember information and thus identify relationships
between features.
The first scheme proposed in this chapter uses 5-second windows of both raw
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ECG and PPG waveforms as inputs. By using raw waveforms as inputs, the
hybrid CNN-LSTM network is able to learn from all of the available informa-
tion, rather than from manually identified features. Avoiding manual feature
selection also has the advantage of removing human bias from training and test-
ing. Additionally, the use of a short, 5-second window of data ensures that BP
can be calculated rapidly and continuously, and is less prone to suffering from
interference than longer windows.
In the second scheme proposed by this chapter, focus was placed on improv-
ing computational efficiency. Twelve features describing the shape of 5-second
segments of ECG and PPG are derived and used as input features. This strategy
minimises the risk of human bias as it focuses on describing what can be seen in
the waveform, rather than deriving complex features such as PTT.
The remainder of this chapter is structured as follows. Section 3.2. presents
the methodology, including schemes for preprocessing, signal quality assessment
and developing the hybrid NNs for BP estimation. Section 3.3. discusses the
results of testing conducted on the NN algorithms to assess their performance.
Finally, Section 3.4. briefly concludes this work and summarises its significance.
3.2 Methodology
3.2.1 Data Acquisition
Deep learning is most successful when large quantities of data are used for train-
ing, validating, and testing the models. The Medical Information Mart for In-
tensive Care (MIMIC) [151] database features many de-identified patient records
from critical care environments and has been used in several significant and high-
impact studies focused on developing biomedical algorithms, including [33, 97].
To train neural networks to estimate both SBP and DBP, ECG and PPG signals
are required. Additionally, reference “true” values for SBP and DBP are needed,
which can easily be derived from arterial blood pressure (ABP) waveforms avail-
able in the MIMIC database. As such, all records that contained ECG, PPG
and ABP waveforms were obtained, resulting in a database comprised of 6,972
unique patients.
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3.2.2 Data Preprocessing
Following acquisition, each record was split into 5-second segments. This seg-
ment length allows for extremely rapid BP estimation, while also providing a
wide enough window to accurately calculate BPs even where the heart rate
is extremely low. Segments were taken sequentially, with no overlap between
segments. This ensured that each segment contained completely unique data.
During the segmentation process, any segments with missing or flatlining signals
were immediately discarded.
3.2.3 Data Selection
Signal quality indices (SQIs) have been developed in several previous works to
assess the quality of ECG signals, using techniques including spectral analysis
[152], fuzzy support vector machines [153], [150], and simple sanity checks [154].
While these works offer significant SQI tools for ECG signal assessment, they
do not consider PPG signals. As such, for this work a straightforward SQI strat-
egy is implemented, comprised of sanity checks for PPG and ECG waveforms.
Heart rate (HR), beat-to-beat (BTB) intervals and waveform heights are calcu-
lated for ECG and PPG in each record. HR values derived from each signal must
be equal and fall within 40-180 bpm for a record to be considered “good” by the
SQI tool. This is the range which is physiologically probable for HR [154] and
thus is a reasonable indicator of signal quality. The consistency of the signal is
also considered by finding the maximum-to-minimum ratio for both beat-to-beat
intervals and peak heights and ensuring that the maximum is no more than 50%
larger than the minimum.
Records were also excluded if pulse pressure (the difference between SBP and
DBP) was not between 20-60 mmHg. Pulse pressure is considered high when
it is over 60 mmHg [155, 156], and is usually indicative of an immediate health
problem. Meanwhile, pulse pressure is considered low beneath 40mmHg and
indicates poor heart function [155, 156], so an intentionally conservative lower
limit of 20 mmHg was chosen for this application given that data is acquired
from critical care units.
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Algorithm 1 Signal Selection Algorithm
Input: hr ppg, hr ecg, ppg peak ratio, ecg peak ratio, ppg btb ratio, ecg btb -
ratio, true sbp, true dbp, pulse pressure
Output: use record
1: if (hr ppg == hr ecg) & (hr ppg > 40) & (hr ppg < 180) & (ppg peak -
ratio < 1.5) &
(ecg peak ratio < 1.5) & (ppg btb ratio < 1.5) &
(ecg btb ratio < 1.5) & (pulse pressure > 20
& (pulse pressure < 60)] then
2: record quality = 1
3: else
4: record quality = 0
5: end if
In Algorithm 1, hr ppg and hr ecg are the HRs calculated from the PPG
and ECG signal respectively. Additionally, ppg peak ratio and ecg peak ratio are
the ratios of the maximum peak height to the minimum peak height for each
signal, while ppg btb ratio and ecg btb ratio are the ratios of the widest to smallest
BTB intervals for each signal. Each of these metrics offers a measure of signal
consistency, which in turn is indicative of signal quality. Lastly, the parameter
pulse pressure is the pulse pressure values calculated from the ABP signal.
After assessing the suitability of all signals using Algorithm 1, the resulting
data was inspected and outlier BP values were excluded. The final database
contained over 200,000 records for use in training and testing of the proposed
NNs.
3.2.4 Feature Extraction
This chapter describes two schemes for prediction of blood pressure. The first
scheme uses the raw ECG and PPG waveforms, while the second scheme uses a
small vector of features which describe the shape of the waveforms. The feature
selection process is described for each scheme as follows.
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Raw Waveform Scheme
In the first scheme, the input features used are the amplitudes of raw ECG and
PPG waveforms over a 5-second period. As ECG and PPG waveforms were
both sampled at 125Hz, the feature vector included 625 amplitude data features
from both the ECG and PPG waveforms, for a total feature vector size of 1,250
amplitude data points.
Feature-Based Scheme
In the second scheme, the aim was to improve computational efficiency by greatly
reducing the number of features used. In selecting which features to extract from
the signals, human bias was minimised by predominantly choosing features of
the signal, rather than features calculated from the signals. In other words, the
majority of the chosen features aimed to describe the shape of the waveform.
For ECG, the waveforms were described by extracting all R, P, T, Q, and
S-wave amplitudes from the signal, as well as the beat-to-beat (BTB) interval
- that is, the time between R-waves. These features are illustrated in Fig. 3.1
below. To quantify the typical R, P, T, Q, and S-waves within the 5-second
signal segment, median was used rather than mean to minimise the impacts of
outliers. Mean was however used to quantify the typical BTB inerval between
R-waves, as the time scale was less likely to be affected by noise than the various
wave heights.
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Figure 3.1: A typical ECG waveform.
The median peak and trough heights of the PPG signal were then calculated
after extracting all peaks and troughs from the signal. The BTB intervals be-
tween two peaks were also extracted, with the mean then taken to quantify the
typical BTB interval. These features are illustrated in the sample PPG signal
shown in Fig. 3.2.
Figure 3.2: A typical PPG waveform.
The few features that required slightly more calculation were PPG wave
height, heart rate, and mean up-time. As illustrated in Fig. 3.3, the PPG
wave height was calculated as the difference between the first peak and trough
heights, while the median of the HRs calculated from the PPG and ECG signals
was used as HR in the feature vector. Lastly, up-time was calculated as the time
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taken for the PPG signal to go from trough to peak. This was calculated for all
trough-peak pairs and averaged to get a mean up-time, which was then used in
the feature vector.
Figure 3.3: Calculation of additional PPG features.
Overall, the feature vector contained 12 important features of the ECG and
PPG signals. These features required minimal calculation and thus minimize
the risk of human bias impacting upon the ability of a NN to learn from the
data. The twelve features used were the R-wave median, S-wave median, Q-
wave median, P-wave median, T-wave median, mean BTB interval of the ECG,
mean BTB interval of the PPG, PPG wave height, heart rate, median PPG peak
height, median PPG trough depth, and mean up time.
3.2.5 Proposed Neural Network
Raw Waveform Scheme
For the task of blood pressure estimation from raw waveforms, a hybridised
deep neural network (DNN) is proposed, combining temporal convolutional lay-
ers with long short-term memory (LSTM) layers, as shown in Fig. 3.4. CNNs
are typically used to identify important features and patterns within a signal, re-
gardless of their location, and have previously been used in the related problems
in ECG anomaly detection [51–53]. Meanwhile LSTM networks perform excep-
tionally well on sequential data due to their ability to ‘remember’ what they
have previously seen. This enables them to draw links between multiple features
readily, and has lead to them being trialled in ECG and BP related problems
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[99, 100, 148]. Combining the two network structures draws on the benefits of
both to create a powerful hybrid NN with strong predictive abilities for sequen-
tial waveform data. The proposed hybrid CNN-LSTM outperformed separate
CNN and LSTM networks with respect to MAE, SD, and error distribution in
preliminary testing.
Figure 3.4: System model of the proposed NN for BP estimation using raw waveforms
as inputs.
The proposed network then utilizes three temporal CNN layers, each with
128 hidden units and utilizing ReLU activation. The first two CNN layers use
a kernel size of 10, while the third uses a kernel size of 4. All CNN layers use a






i ∗ xm(i-1) + bji) (3.1)
where yij is the jth feature map of the ith layer. Convolution is denoted with the
∗ symbol. Weights wjni describe the nth weight of the jth feature map from the
(i−1)th layer, where n = 1, ..., N . The outputs of the (i−1)th layer are denoted
as xm
(i-1), while bias is denoted as bj for the jth bias term of the ith layer. Biases
are initialised to zero and updated using the Adam optimizer algorithm [157]
with a learning rate of 0.01.
Maximum pooling is applied following each convolutional layer, as shown in
Fig. 3.4. Pool1 and Pool2 both use pool and stride sizes of 10, while Pool3 uses
pool and stride sizes of 4. Applying maximum pooling after CNN downsamples
the outputs, which aids in the prevention of overfitting.
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As shown in Figure 3.4, the unravelled ECG and PPG data is passed to the
regression network as a feature vector, before passing through an efficient net-
work comprised of multiple interleaved convolutional, dimensionality reduction,
and LSTM layers. The output of the final hidden layer is passed to a densely
connected layer. This output layer utilises ReLU activation to predict blood
pressure as a decimal value. The same network structure was used for training
separate SBP and DBP prediction networks.
Following the convolutional section of the network, there two bidirectional
LSTM network layers with 128 hidden units. Bidirectional LSTMs (BiLSTMs)
consider data in both original and reversed order, allowing them to learn from
values both in the past and future within the sequence. Results from both
forward and reversed sequences are concatenated to provide the overall output,
however the mathematical structure for both passes remains the same as standard
LSTM. This mathematical process is described Eqns. (3.2-3.7) below.
c̃t = tanh(wc[ a(t-1), xt] + bc) (3.2)
f t = σ(wf[ a(t-1), xt] + bf) (3.3)
ut = σ(wu[ a(t-1), xt] + bu) (3.4)
ot = σ(wo[ a(t-1), xt] + bo) (3.5)
ct = ut • c̃t + f t • c(t-1) (3.6)
at = ot • tanh(ct) (3.7)
where the weights are wc, wf, wu and wo, while biases are bc, bf, bu and bo.
Biases and weights are learnt using the Adam optimization algorithm [157] with
a learning rate of 0.01. The previous layer output is denoted as a(t-1), while xt
is the input to timestep t. Lastly, Equations (3.6) and (3.7) are the updated cell
state and layer output respectively.
The final layer of the network is a simple densely-connected node that pro-
vides the final output of the network, which is the prediction for blood pressure.
This network structure was used for training and testing of networks for SBP
and DBP estimation separately.
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Feature-Based Scheme
For the feature-based scheme, a shallower hybrid CNN-LSTM network was used.
As shown in Figure 3.5, the 12-feature vector is used as the input to the network
comprised of multiple convolutional, pooling, and LSTM hidden layers. Each
layer had 128 hidden units, with the CNN layers featuring a kernel size of 2
with stride of 1 and the maximum pooling layers featuring pool and stride sizes
of 2. The output of the final hidden layer is passed to a densely connected
layer utilizing sigmoid activation, which then determines the most likely blood
pressure.
Figure 3.5: System model of the proposed NN for BP estimation using twelve features
of the waveforms as inputs.
This network was able to be shallower than that of the raw waveform scheme,
as fewer input features lead to convergence on a solution without as many lay-
ers. The layer depth illustrated in Fig. 3.5 was found to provide the optimal
MAE, with increased depth showing no improvement with respect to this key
parameter. Additionally, unidirectional LSTM was used rather than bidirec-
tional LSTM in this case, as the latter showed no improvement in predictive
performance. Therefore it was preferable to use unidirectional LSTM, which
offers lower computational cost. As with the raw waveform scheme, biases are
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initialised to zero and updated using Adam optimization [157] with a learning
rate of 0.01.
3.2.6 Training & Testing of the NNs
The networks for both the raw waveform and feature-based scheme were trained
using 80% of the data. A further 10% of the data was used for validation of SBP
and DBP, allowing for fine-tuning of the hyperparameters. The final 10% of data
remained unseen to the networks for use in testing.
For the raw waveform network, training and validation was performed over
750 epochs with mean absolute error (MAE) used as the loss function. Mean-
while, the feature-based network converged rapidly after 50 epochs, with any fur-
ther iterations found to cause overfitting to the training set. For both schemes,
network performance was checked at the end of each iteration; if the network was
achieving a lower MAE than all previous iterations, then the network weights
were saved. If not, then training moved on to the next iteration. This ensured
that the best weight combination encountered during training and validation was
used for the final network.
Testing was then conducted using the highest-performing networks for SBP
and DBP estimation in each scheme. The predictions made by the SBP and DBP
networks are also combined to produce a prediction for mean arterial pressure
(MAP), which represents the average pressure in a person’s arteries during a
single cardiac cycle [82] and is mathematically defined as follows:
MAP =
SBP + (2×DBP )
3
The results achieved by the networks were recorded and analysed, and are
presented with discussion in the following section.
3.3 Results & Discussions
In evaluating the performance of the proposed CNN-LSTM model for the estima-
tion of SBP, DBP, and MAP, two widely accepted standards for the approval of
blood pressure devices for use in clinical environments are considered - the British
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Hypertension Society (BHS) protocol and the Association for the Advancement
of Medical Instrumentation (AAMI) standard.
Furthermore, this section evaluates the level of agreement between the cal-
culations made by the CNN-LSTM networks and the expected SBP, DBP, and
MAP values as determined from ABP waveforms within the MIMIC-III database,
which were obtained using gold-standard intra-arterial blood pressure measure-
ment. The schemes proposed in this chapter are also compared to previous
related works, highlighting the improvement that the proposed schemes make to
accurate blood pressure estimation.
3.3.1 Comparison to the BHS Protocol
The BHS protocol [103] assigns grades of A-D to blood pressure measurement
devices, based on the percentages of measurements that achieve absolute differ-
ences of less than 5mmHg, 10mmHg, and 15mmHg respectively, when compared
to gold-standard measurement techniques such as intra-arterial monitoring. The
grading criteria established by the BHS protocol are illustrated in Table 2.1. De-
vices that achieve grades of A or B in accordance with the BHS grading criteria
are considered suitable for clinical use, while those that achieve lower grades are
not recommended for clinical use.
Raw Waveform Scheme
As shown in Table 3.1, the proposed raw waveform scheme satisfies the require-
ments for an A grade device in the estimation of SBP, DBP, and MAP, and thus
would be recommended for use in clinical settings.
Table 3.1: Assessment of raw waveform scheme based on BHS protocol.
Absolute Difference (mmHg)
≤5 ≤10 ≤15 Grade
SBP 67.66% 89.82% 96.82% A
DBP 82.79% 96.12% 99.09% A
MAP 84.21% 97.38% 99.58% A
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Feature-Based Scheme
As shown in Table 3.2, the feature-based scheme also comfortably satisfies the
requirements for an A grade device in the estimation of SBP, DBP, and MAP.
It can be seen that fewer predictions fell within each error category than with
the raw waveform scheme, however the maximum grade for the BHS standard is
still comfortably achieved.
Table 3.2: Assessment of feature-based scheme based on BHS protocol.
Absolute Difference (mmHg)
≤5 ≤10 ≤15 Grade
SBP 64.96% 89.90% 97.76% A
DBP 82.08% 96.18% 98.86% A
MAP 81.04% 96.91% 99.50% A
3.3.2 Comparison to the AAMI Protocol
Blood pressure devices are often evaluated with respect to both the AAMI and
BHS protocols, as they have different mechanisms for determining device suitabil-
ity. The AAMI standard [102] states that a device must have a mean difference
of ≤5 mmHg and a standard deviation (SD) of ≤8 mmHg from gold standard
measurements. Devices are assigned a grade of “Pass” if the aforementioned
criteria are met, otherwise the device is given a grade of “Fail”. Each of the
proposed schemes were compared to the AAMI standard as follows.
Raw Waveform Scheme
As illustrated in Table 3.3, the raw waveform scheme comfortably achieve “Pass”
grades with respect to the AAMI criteria. The proposed algorithms achieve
impressively low MAEs and SD in estimation of all BP parameters, and would
be suitable for implementation in healthcare.
Feature-Based Scheme
After testing the proposed CNN-LSTM model on the test set, it was found that
the algorithm achieved acceptably low MAE and SD in estimating SBP, DBP, and
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Table 3.3: Assessment of raw waveform scheme based on AAMI standard.
MAE (mmHg) SD (mmHg) Grade
SBP 4.4097 6.1075 Pass
DBP 2.9105 4.2347 Pass
MAP 2.7663 3.8832 Pass
MAP, as is illustrated in 3.4. This model therefore achieves a comfortable “pass”
grade in all areas of BP estimation according to the AAMI standard. While MAE
is higher than was achieved by the raw waveform scheme, this scheme would still
be suitable for healthcare applications.
Table 3.4: Assessment of feature-based scheme based on AAMI standard.
MAE (mmHg) SD (mmHg) Grade
SBP 4.5010 5.9678 Pass
DBP 3.0167 4.2987 Pass
MAP 3.0517 4.1357 Pass
3.3.3 Analysis of Error Distribution
Accurate measurement of BP is of vital importance in healthcare applications.
To further analyse the performance of the proposed schemes, error histograms
were generated for SBP, DBP and MAP prediction to inspect the spread of errors.
Raw Waveform Scheme
Figs. 3.6-3.8 present the error distributions for the SBP, DBP, and MAP predic-
tions generated by the raw waveform scheme. Each of these histograms clearly
shows that ‘0’ is the most common error, and that most other errors are also
extremely low.
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Figure 3.6: Error histogram for SBP (raw waveform scheme).
Figure 3.7: Error histogram for DBP (raw waveform scheme).
Figure 3.8: Error histogram for MAP (raw waveform scheme).
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Feature-Based Scheme
The error distributions for SBP, DBP, and MAP predictions made by the feature-
based scheme are illustrated in Figs. 3.9-3.11. Each of these histograms clearly
shows that ‘0’ is the most common error, and that most other errors are also
extremely low. The error histograms for the feature-based scheme show a similar
distribution of error as was achieved by the raw waveform scheme.
Figure 3.9: Error histogram for SBP (feature-based scheme).
Figure 3.10: Error histogram for DBP (feature-based scheme).
Chapter 3 51
Machine Learning for Non-Invasive Patient Health Monitoring
Figure 3.11: Error histogram for MAP (feature-based scheme).
3.3.4 Level of Agreement between Intra-arterial Monitor-
ing and CNN-LSTM Networks
Bland Altman plots are a key method for assessing the level of agreement between
two methods of measurement, particularly in medical applications. These plots
illustrate the difference between two measurements compared to the mean of the
two measurements, and as such a high density of data near the central ‘mean
difference’ line and narrow ‘limits of agreement’ (LOAs) indicate a strong level
of agreement between measurements.
Raw Waveform Scheme
In Figs. 3.12-3.14, the SBP, DBP, and MAP predictions made by the raw wave-
form scheme are compared with the values obtained using the current gold-
standard of BP monitoring, intra-arterial measurement. Each figure clearly
shows a high density of points near the mean difference line with narrow LOAs
for SBP, DBP, and MAP graph. As such, it is clear that there is a high level
of agreement between the proposed CNN-LSTM models the respective measure-
ments made via intra-arterial monitoring.
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Figure 3.12: Bland Altman plot for SBP (raw waveform scheme).
Figure 3.13: Bland Altman plot for DBP (raw waveform scheme).
Figure 3.14: Bland Altman plot for MAP (raw waveform scheme).
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To further evaluate the level of agreement between the proposed scheme and
intra-arterial BP measurement, regression plots were generated and the coeffi-
cients of correlation were calculated to quantify the strength of the relationship
between measurements. In all regression plots, the dashed black line shows the
theoretical “perfect” correlation, while the solid black line represents the actual
correlation. The regression plots for SBP, DBP, and MAP are shown in Figs.
3.15, 3.16 and 3.17 respectively.
Figure 3.15: Regression plot for SBP (raw waveform scheme).
Figure 3.16: Regression plot for DBP (raw waveform scheme).
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Figure 3.17: Regression plot for MAP (raw waveform scheme).
Each regression plot illustrates strong positive linear correlation between the
“true” values and the actual predictions generated by the raw waveform CNN-
LSTM model. The calculated correlation lines fall close to ideal correlation
lines in all cases. To further analyse correlation, the correlation coefficients were
calculated, with the results displayed in Table 3.5.
Table 3.5: Coefficients of correlation for the raw waveform scheme.




These results clearly confirm the strong positive linear relationships between
the predictions for SBP, DBP, and MAP made by the proposed scheme when
compared with the respective measurements acquired with invasive intra-arterial
monitoring.
Overall, it is evident that there is a high level of agreement and strong cor-
relation between the raw waveform scheme and the current gold-standard for
blood pressure estimation. As the proposed scheme is entirely non-invasive, un-
like intra-arterial monitoring, these results are extremely promising for the future
of healthcare, especially for at-risk patients such as premature babies and the
elderly.
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Feature-Based Scheme
Bland-Altman analysis was also performed for the feature-based scheme, with
Figs. 3.18-3.20 showing the Bland Altman plot for SBP, DBP, and MAP. As
shown in these figure, there is a high level of agreement between the values
calculated by the feature-based CNN-LSTM model and that of the intra-arterial
monitoring, with narrow LOAs and clustering of data points around the mean
difference line visible in all graphs.
Figure 3.18: Bland Altman plot for SBP (feature-based scheme).
Figure 3.19: Bland Altman plot for DBP (feature-based scheme).
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Figure 3.20: Bland Altman plot for MAP (feature-based scheme).
To further evaluate the level of agreement between intra-arterial BP and
the feature-based scheme, regression plots were generated and the coefficients of
correlation were calculated. In Figs. 3.21-3.23, the solid black line represents
the line of best fit to the data, while the dashed black line illustrates what the
“ideal” linear regression would have been. A reasonable level of agreement is seen
between gold-standard intra-arterial monitoring and the feature-based scheme in
each figure, however this level of agreement is not as strong as was seen between
intra-arterial monitoring and the raw waveform scheme.
Figure 3.21: Regression plot for SBP (feature-based scheme).
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Figure 3.22: Regression plot for DBP (feature-based scheme).
Figure 3.23: Regression plot for MAP (feature-based scheme).
The correlation coefficients are shown in Fig. 3.6, with all confirming the
positive linear relationship between intra-arterial measurements and predictions
made by the proposed CNN-LSTM networks in all categories of BP measurement.
In each case, the correlation coefficient was lower than those achieved by the raw
waveform scheme, but still reasonably strong.
Table 3.6: Coefficients of correlation for the feature-based scheme.
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3.3.5 Comparison to Previous Works
Several works that are strongly related to this work are presented in [33, 34,
36–38, 98]. Each of these methods utilises PPG and ECG signals to predict
blood pressure, though preprocessing and segment lengths vary. Several of these
works utilise the MIMIC-II database [34, 38, 158] or MIMIC-III database [36],
while others utilise small databases that were independently acquired [37, 98].
In this section, the results obtained by the NNs proposed in this chapter are
compared with the best results achieved by the previous literature. The work in
[36] presented results from several databases, and as such the results that they
obtained using MIMIC-III data are used in comparisons, as these results are the
most directly comparable to this work.
In Table 3.7, the models developed in previous works are compared to the
proposed CNN-LSTM networks with respect to the BHS protocol. In terms
of SBP, this table shows that the proposed raw waveform and feature-based
schemes outperform the previous state-of-the-art works. The proposed schemes
are the only ones to have achieved an ‘A’ grade for SBP estimation across all data
analysed. This comparison also shows that the raw waveform scheme performs
marginally better than the feature-based scheme in terms of the BHS protocol
criteria, achieving more predictions under each error threshold.
Table 3.7: Comparison of schemes based on the BHS protocol.
Absolute Difference (mmHg)
≤5 ≤10 ≤15 Grade
Kachuee SBP 34.1% 56.5% 72.7% D
[33] DBP 62.7% 87.1% 95.7% A
MAP 54.2% 81.8% 93.1% B
Mousavi SBP 71% 77% 84% C
[34] DBP 84% 92% 97% A
MAP 79% 83% 93% B
Miao SBP 51% 81% 94% B
[98] DBP 62 % 92% 99% A
Continued on next page
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Table 3.7 – continued from previous page
Absolute Difference (mmHg)
≤5 ≤10 ≤15 Grade
MAP 60% 90% 98% A
Song SBP N/A N/A N/A B
[37] DBP N/A N/A N/A A
MAP - - - -
Miao SBP 50.07% 76.41% 90.39% B
[36] DBP 65.66% 89.77% 96.63% A
MAP 65.14% 89.58% 96.61% A
Raw Waveform SBP 67.66% 89.82% 96.82% A
Scheme DBP 82.79% 96.12% 99.09% A
MAP 84.21% 97.38% 99.58% A
Feature-Based SBP 64.96 % 89.90% 97.76% A
Scheme DBP 82.08% 96.18% 98.86 % A
MAP 81.04% 96.91% 99.50% A
The proposed schemes also perform extremely well for DBP estimation when
compared to the previous works. As shown in Table 3.7, the raw waveform
scheme again performs slightly better than the feature-based scheme. However,
both schemes definitively outperform the DBP prediction networks presented in
other works. While the work in [34] achieved a higher percentage of results with
≤5 mmHg error, the proposed schemes each had a higher percentage of errors
≤10 mmHg and ≤15 mmHg. This indicates that the work in [34] has overfit
to the data, while the networks proposed by this chapter have not suffered from
overfitting, and therefore generate fewer extremely high errors. While all schemes
for DBP estimation achieved grades of ‘A’ and therefore could be recommended
for use by the BHS for this particular parameter, the raw waveform scheme has
achieved the lowest number errors greater than 10 mmHg and thus would be
considered the most suitable for clinical use.
MAP prediction is also considered in Table 3.7, which compares the schemes
proposed in this chapter with previous works. No results for MAP were presented
by [37], but this important diagnostics parameter was examined in [33, 34, 36,
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98]. As shown in Table 3.7, both of the proposed schemes for MAP estimation
outperform the previous works. With 99.19% of errors falling under 15 mmHg
for the raw waveform scheme, it is clear that this scheme has very few high-
range errors when compared to previous state-of-the-art works. Only the schemes
proposed by this chapter and the work presented in [36, 98] achieve the grade of
‘A’, however the schemes proposed here each had significantly fewer high-range
errors exceeding 5 mmHg and thus would be the most suitable for clinical use.
Once again, the raw waveform scheme slightly outperforms the feature-based
scheme.
As shown in Table 3.8, the proposed schemes also compare favourably with
previous works with respect to the AAMI standards. In all cases, the grade
was determined based on MAE and standard deviation (SD). Table 3.8 shows
that the schemes proposed in this chapter and the scheme presented in [37]
are the only ones to achieve a grade of “Pass” for SBP estimation. However,
the raw waveform scheme has a lower MAE and SD than that of [37], while the
feature-based scheme achieves results comparable to those presented in [37]. The
proposed schemes each have a marginally higher MAE and SD than the scheme
in [34] for DBP and MAP, however this is likely due to the overfitting seen in
Table 3.7 for [34].
Table 3.8: Comparison of schemes based on the AAMI standard.
Error Metrics (mmHg)
....MAE.... SD Grade
Kachuee [33] SBP 11.80 9.88 Fail
DBP 5.83 5.71 Fail
MAP 5.92 5.25 Fail
Mousavi [34] SBP 3.97 8.901 Fail
DBP 2.43 4.173 Pass
MAP 2.61 4.911 Pass
Miao [98] SBP 6.13 7.76 Fail
DBP 4.54 5.52 Pass
MAP 4.81 6.03 Pass
Continued on next page
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Table 3.8 – continued from previous page
Error Metrics (mmHg)
....MAE.... SD Grade
Song [37] SBP 4.8 6.0 Pass
DBP 4.8 6.0 Pass
MAP N/A N/A N/A
Sharifi [38] SBP 7.83 9.1 Fail
DBP 4.86 5.21 Pass
MAP N/A N/A N/A
Miao [36] SBP 7.10 9.99 Fail
DBP 4.61 6.29 Pass
MAP 4.66 6.36 Pass
Raw Waveform Scheme SBP 4.4097 6.1075 Pass
DBP 2.9105 4.2347 Pass
MAP 2.7663 3.8832 Pass
Feature-Based Scheme SBP 4.5010 5.9678 Pass
DBP 3.0167 4.2987 Pass
MAP 3.0517 4.1357 Pass
Overall, the proposed raw waveform and feature-based schemes for the pre-
diction of SBP, DBP, and MAP both perform strongly and have been shown to
generalize well to new data. For SBP, DBP and MAP, the proposed models both
achieved ‘A’ and “Pass” grades for the BHS and AAMI standard respectively.
The schemes proposed in this chapter were the only schemes to achieve these
high results for all three BP metrics.
Additionally, the schemes proposed by this chapter were the only schemes to
achieve both ‘A’ and “Pass” grades for SBP measurement. The raw waveform
scheme exhibited superior predictive performance when compared to the feature-
based scheme, achieving lower MAE for SBP, DBP, and MAP, as well as stronger
results with respect to the BHS criteria.
A strong level of agreement with gold-standard measurements was achieved
by both schemes, as shown by the Bland-Altman and regression plots. However,
the regression plots indicate stronger positive correlation between intra-arterial
62 Chapter 3
Machine Learning for Non-Invasive Patient Health Monitoring
monitoring and raw waveform scheme predictions than was seen when comparing
intra-arterial monitoring with the feature-based scheme. These results suggest
that both of the proposed schemes are highly suitable options for non-invasive BP
estimation from ECG and/or PPG waveforms, with the raw waveform scheme
achieving the best predictive performance and level of agreement with intra-
arterial monitoring.
3.3.6 Computational Efficiency
To compare the computational efficiency of the two schemes proposed in this
chapter, speed testing was conducted on a NVIDIA GeForce GTX 1070 graphics
card. The time taken for the model in the feature-based scheme to make a
single prediction was 3.86 × 10-6 seconds, while the raw waveform model took
1.20× 10-4 seconds to make a prediction. This means that the proposed feature-
based scheme is capable of making predictions 31× faster than the raw waveform
scheme. While the higher performance of the raw waveform scheme would make it
more suitable for clinical applications, the significantly improved computational
efficiency with slight reduction in performance would make the proposed feature-
based scheme more suitable for wearable devices.
3.4 Conclusion
In this work, two schemes based on hybridized CNN-LSTM neural networks
are proposed for the estimation of blood pressure. The first scheme utilized
raw ECG and PPG waveforms as inputs, showing that with minimal data pre-
preprocessing, accurate estimations of SBP, DBP, and MAP can be achieved with
the CNN-LSTM network structure. In the second scheme, 12 straightforward
features describing the shape of ECG and PPG waveforms are extracted and used
as inputs to a shallower CNN-LSTM neural network, with strong performance
again seen for the prediction of SBP, DBP, and MAP.
When compared to standards set by the reputable healthcare bodies of BHS
and AAMI, the proposed networks performed extremely well. The two schemes
each met the requirements set by AAMI and achieved grades of ‘A’ in accordance
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with the BHS protocol for SBP, DBP, and MAP. This success indicates that a
device implementing either of the proposed schemes would be recommended for
clinical use by these professional bodies.
Furthermore, when the proposed models are compared to previous state-
of-the-art schemes in the literature, the proposed schemes outperformed each
previous work. Previous schemes performed well in measurement of certain BP
parameters, but not in others. Additionally, overfitting was apparent in some
schemes. Meanwhile, the schemes proposed in this chapter are shown to have
fit the data extremely well through their high performance on previously unseen
data. Additionally, the proposed schemes were the only ones to achieve grades
of ‘A’ for the BHS protocol and ‘pass’ for the AAMI standard across all BP
measurements.
When comparing the two proposed schemes directly, it was found that the
raw waveform scheme showed stronger performance by the AAMI and BHS cri-
teria than the feature-based scheme, as well as demonstrating a higher level
of agreement with the gold-standard intra-arterial monitoring. However, the
feature-based scheme still met the requirements of each standard and was found
to be capable of making a prediction 31x faster than the raw waveform scheme.
Overall, the raw waveform scheme would be more suitable where computational
power is readily available, while the feature-based scheme would be suitable for
wearable devices as it offers lower-power computation without significant com-
promise on predictive performance.
Overall, the performance of the proposed algorithms indicate that hybrid
CNN-LSTM networks are highly suitable for blood pressure prediction. Imple-
menting the proposed algorithms into appropriate healthcare monitoring devices
would likely result in non-invasive, continuous, and highly accurate blood pres-
sure measurements for a number of applications, from intensive care to smart
watches.
The proposed algorithm addresses the first research problem of blood pres-
sure monitoring (presented in Section 1.2.1) and leads to the first two original
contributions presented in Section 1.3. This chapter offers substantial contri-
bution to the literature through accurate schemes for both low-power wearables
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and higher-powered devices such as medical equipment and computers. The high
performance of CNN-LSTM networks in this chapter lead to the exploration of




Machine Learning Approach to Cal-
culating Respiratory Rate from Heart
Rate Variations
This chapter contains materials included in the following manuscript, which has
been submitted to PLOS One
[3] S. Baker, W. Xiang, and I. Atkinson, “Determining respiratory rate from
photoplethysmogram and electrocardiogram signals using respiratory quality in-
dices and neural networks,” PLoS One, vol. 16, no. 4, p. e0249843, February
2021.
4.1 Introduction
Respiratory rate (RR) is a fundamental physiological parameter, and abnormal-
ity in this vital sign is one of the earliest indicators of critical illness. One recent
study found that elevated respiratory rate was a key predictor of clinical deterio-
ration within 48 hours of discharge from the emergency department (ED) [104].
Another classical study determined that the occurrence of at least one RR ≥
27 breaths per minute (BrPM) in a 72 hour period was a strong predictor of
cardiac arrest [105]. Elevated RR has also been linked to increased mortality
[106], while relative changes in RR have been shown to indicate patient stability
[107]. In children, elevated RR is a primary indicator of pneumonia, an infection
that is the most common cause of death in children aged 0-5 [13, 14]. Clearly,
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abnormalities or variations in the RR are key indicators of clinical deterioration.
Despite the clinical significance of RR, several studies have noted that it is
historically less recorded than other vital signs [15, 104, 108, 109]. This has
somewhat improved with the introduction of the Modified Early Warning Score
(MEWS) [108], which incorporates measurement of RR. However, one study
observed that nurses still don’t measure RR in 50% of cases [15]. Time constraints
and the lack of equipment for measuring RR were both cited as reasons for not
monitoring this parameter.
This lack of recording can be partially attributed to the fact that there is a
lack of tools available for automatically measuring RR. Currently, most common
methods for automatic RR measurement rely on oronasal systems incorporating
sensors including capnography, temperature, and moisture sensors [14]. However,
these have not been widely adopted, with issues related to cost, wearability, and
accuracy identified for existing automated devices [14].
Manual measurement remains the accepted method for determining RR. To
obtain RR, it is recommended that healthcare staff count the number of breaths
a patient takes over a one-minute period [13]. However, several studies have
found that both doctors and nurses estimate respiratory rate over shorter time
periods, or without counting the breath at all [16, 110]. Accuracy of manual RR
calculations can be affected by patient awareness [15], as well as time constraints,
interruptions from patients and other staff, and patient agitation [14, 110].
In addition to the complications associated with obtaining an accurate man-
ual RR measurement, there is also a significant time cost. One study found
that as much as 7.2% of nurses’ time was spent performing patient assessment,
including measurement of RR [17]. There are approximately 3 million registered
nurses in America, earning an average of $75,510 USD per annum each as of
May 2018 [159]. Thus, the total financial cost incurred by time nurses spend on
patient assessment exceeds 16 billion USD per year.
Given the major limitations in measuring RR, it is clear that a reliable method
of automatic and continuous monitoring of this vital sign in a non-invasive man-
ner would significantly improve patient outcomes in hospitals. Additionally,
given the usefulness of RR as an early indicator of critical illness, continuous
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at-home measurement of RR could be lifesaving for at-risk patients living alone.
Several recent studies have investigated the use of photoplethysmogram (PPG)
and echocardiogram (ECG) signals to derive RR in a wearable and non-invasive
manner [39, 40, 42–45]. Respiration modulates the ECG and PPG signals in three
main ways - baseline wander (BW) modulation, amplitude modulation (AM)
and respiratory sinus arrhythmia (RSA) modulation, more commonly known as
frequency modulation (FM). These modulations are caused by movement as-
sociated with breathing, and various responses to the change in intrathoracic
pressure during respiration [160].
In order to accurately estimate RR, several recent studies have developed res-
piratory quality indices (RQIs) to determine which of the extracted modulations
are of the highest quality [43, 44, 117]. This in turn allows for identification of
which modulation-extracted RRs are realistic, thus allowing for more accurate
estimation of actual RR.
Interestingly, there are very few studies that have attempted to estimate RR
from PPG and ECG using machine learning (ML). The best performing ML-
enabled technique was presented in [43], where a mean absolute error (MAE) of
0.71 BrPM was achieved using linear regression on a small database. While these
are good results, this chapter demonstrates that they can be improved upon by
instead using neural networks (NNs) in combination with the proposed novel
RQI scheme.
In this chapter, an RQI scheme is developed for assessing the quality of
modulation-extraction respiration signals. The proposed scheme uses statistics
regarding the signal variation to assign ‘good’ or ‘bad’ ratings to RRs calculated
from modulation-extracted signals. Bidirectional long short-term memory (BiL-
STM) neural networks are trained and tested, comparing the performance in two
scenarios: one where only RR features are used as features, and the other where
both RR and corresponding RQIs are used.
The remainder of this chapter is structured as follows. Section 4.2. describes
the methodology utilized for obtaining signal quality and an overall RR estima-
tion using various NN structures. Section 4.3. presents results and discussion
before Section 4.4. concludes the chapter and provides recommendations for
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Data for this work was obtained from the open-source Medical Information Mart
for Intensive Care (MIMIC-III) database [151], which features an extremely large
number of records from intensive care units (ICUs). To train the neural networks,
ECG and PPG signals were needed to derive RR from the BW, AM, and FM
modulations. Additionally, a reference “true” RR signal was needed to provide
the neural networks with an expected output RR. As such, the PhysioBank
ATM tool [161] was used to obtain a list of all records containing ECG, PPG,
and respiratory waveforms from the MIMIC-III database. Then, a Python script
was developed to download all relevant records as MATLAB-compatible files,
utilizing several functions from the Waveform Database (WFDB) Toolbox [162].
After running this script, a total of 8,781 records were obtained. No exclusions
were made based on patient demographics, diagnoses or treatments received, as
the goal of this chapter was to develop an all-inclusive scheme that could measure
respiratory rate irrespective of whether respiration was being affected by health
conditions or respiratory support treatments.
4.2.2 Preprocessing Data
The primary preprocessing performed was the denoising of ECG and PPG sig-
nals. Many of the ECG and PPG signals were affected by baseline wander that
could be attributed both to respiration and other movement. This BW prevents
accurate derivation of respiration from amplitude and frequency modulations,
and also inhibits signal quality assessment. To eliminate all BW from each in-
dividual ECG signal, a sixth-order polynomial was fitted to the ECG signal and
then subtracted from it. Meanwhile, a low-pass Chebyshev filter was applied to
each PPG signal and then subtracted from it to remove frequency components
outside of the range of the heart rate. The order of the filter was determined
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dynamically based on the sampling frequency of each signal. In all cases, the
original ECG and PPG waveforms were retained for estimation of BW due to
respiration later on.
After removing the low-frequency BW components from the signals, it was
observed that many ECG signals still appeared noisy. To denoise the ECG
signals, a seventh-order Savitsky-Golay filter was utilized. This filter type was
chosen due as they are well-known to preserve small details of a waveform, such
as the Q- and S-waves found in ECG signals.
After signals were denoised, all records including ECG, PPG and respiratory
signals were split into segments. In this chapter, three different segment lengths
are trialled to determine the most suitable length for accurate RR prediction.
The segments chosen were 20, 30, and 60 seconds. These segment lengths are
commonly used in the literature, allowing for fair comparison. They also each
enable very frequent RR estimation, while also providing a wide enough window
to accurately calculate even very low RRs. At this point, any segment with a
missing signal or flat-lining signal was discarded.
For each 20-second segment, the R-waves (or peaks) of the ECG signals were
found, as well as the peaks of the PPG and reference RR signals. Additionally,
the beat-to-beat intervals were calculated for PPG and ECG signals, and the
breath-to-breath (BrTBr) interval was calculated for RR signals. Heart rate
(HR) was then calculated from both the PPG and ECG signals, before RR was
calculated from the reference respiration signal. This extracted information was
then used by a purpose-built signal quality index (SQI) as described in the next
section, to determine the overall quality of the segment and thus the segment’s
suitability for training and testing the neural networks.
Furthermore, the RR of each 20-second segment was calculated by finding the
average period between peaks of the respiration signal. This period represents
one full breath, and thus the RR was calculated using the following formula:
RRtrue =
60
mean(BrTBr1, BrTBr2, ..., BrTBrn)
(4.1)
where ‘BrTBr’ represents a breath-to-breath interval measured in seconds,
‘n’ is the number of BrTBr intervals within for the 20-second respiratory signal,
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and the ‘RRtrue’ is taken as the “true RR” for that segment.
4.2.3 Signal Quality Assessment
Signal quality assessment is vital to ensure that neural networks are learning
from realistic data. One significant work [154] found that simple conditional
statements can be used to effectively assess the quality of PPG, ECG, and blood
pressure (BP) signals. In these works, various sanity checks were performed to
determine the quality of a signal, such as ensuring that heart rate (HR) and
beat-to-beat (BTB) intervals were within reasonable ranges. Reasonable range
for RR were determined based on clinical medicine resources
In this work, PPG and ECG signals are considered with respect to calculating
RR, and as such the quality of the respiration signal is also vital. As such,
this work develops an SQI tool based on conditional statements relevant to the
problem in order to successfully classify a record containing PPG, ECG and
respiration signals as either “good” or “bad” based on a series of conditional
statements. This is described by the following algorithm:
Algorithm 2 Signal Quality Index Algorithm
Input: hr ppg, hr ecg, ppg peak ratio, ecg peak ratio, ppg btb ratio, ecg btb -
ratio, true rr, true rr peak ratio, true rr brtbr ratio
Output: signal quality
1: if [(abs(hr ppg - hr ecg) < 10) & (hr ppg > 40) & (hr ppg < 180) &
(ppg peak ratio < 1.5) &
(ecg peak ratio < 1.5) & (ptp btb ratio < 1.5) &
(ecg btb ratio < 1.5) & (true rr > 8) &
(true rr < 35) & (true rr peak ratio < 1.5)
& (true rr brtbr ratio < 1.5)] then
2: signal quality = 1
3: else
4: signal quality = 0
5: end if
In this algorithm, hr ppg and hr ecg are the HR values calculated from the
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PPG and ECG signals, respectively. They are compared to each other to verify
that they were acceptably similar, then hr ppg was checked to ensure that HR
was within the physiologically probable range of 40-180 bpm [78]. Meanwhile,
ppg peak ratio, ecg peak ratio and true rr peak ratio represent the ratio of the
maximum to minimum peak heights for the PPG, ECG and reference RR signals
respectively, and ppg btb ratio, ecg btb ratio and true rr brtbr ratio represent the
ratio of maximum to minimum PPG signal BTB intervals, ECG signal BTB
intervals and reference RR signal BrTBr intervals respectively. It was checked
that each of these ratios was <1.5 to ensure that there was acceptable consistency
within each individual signal, as consistency is a strong indicator of signal quality.
Lastly, true rr represents the RR extracted from the reference signal using Eq.
4.1, and it was checked that this fell within the conservative range of 8-35, as
the RR of a healthy adult would fall between 15-30 BrPM [163] but within
an ICU environment it is likely that RRs across critically ill patients would be
highly variable. Records that met all criteria were assigned a signal quality of 1,
meaning “good”, while failure to meet any criteria resulted in a signal quality of
0, or “bad”.
After testing all 20-second segments with the SQI tool, a total of 19,084
“good” records were found. The next stage was to extract features from each
of these signals for use in training the neural networks. This was a multi-step
process, which begins with the extraction of respiration-induced modulations
from the ECG and PPG signal as discussed in the following subsection.
4.2.4 Extracting Respiratory Signals from ECG and PPG
If PPG and ECG signals were recorded with no interference from respiration
or movement, they would appear as is shown in Fig. 4.1. However, this is not
the reality. Recall that respiration can modulate the ECG and PPG signals
in three key ways - baseline wander (BW) modulation, amplitude modulation
(AM) and frequency modulation (FM) caused by respiratory sinus arrhythmia.
As previously discussed, one or more respiratory modulations may be absent from
the PPG and ECG signals of some patients. As such, endeavouring to extract all
three key modulations from both the ECG and PPG signal will greatly enhance
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a neural network’s ability to estimate true RR.
Figure 4.1: Sample ECG and PPG unaffected by respiration.
Extracting Respiratory Signals
In the context of respiration, BW is the overall shift in the baseline of an ECG or
PPG signal due to respiration, as is shown in Fig. 4.2. BW was obtained by low-
pass filtering the ECG and PPG signals. Hereafter the BW signals extracted from
the PPG and ECG signals are denoted as PPG-BW and ECG-BW, respectively.
Meanwhile, AM presents as the variation in peak heights in the ECG and PPG
signals, after BW has been removed, as shown in Fig. 4.3. Finally, FM presents
in ECG or PPG signals as varying beat duration, as shown in Fig. 4.4. Thus,
AM and FM respiration signals are easily derived from the peak heights and BTB
intervals of the waveforms, respectively. The AM and FM signals extracted from
PPG and ECG are henceforth denoted as PPG-AM, PPG-FM, ECG-AM, and
ECG-FM.
Figure 4.2: BW in the ECG and PPG signals.
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Figure 4.3: AM in the ECG and PPG signals.
Figure 4.4: FM in the ECG and PPG signals.
After BW, AM and FM signals were extracted from the PPG and ECG sig-
nal, peaks and troughs of each signal were calculated and stored in six separate
vectors. Breath-to-breath intervals, as well as the intervals between trough loca-
tions, were also calculated and stored in six additional vectors. These parameters
were then used by the developed respiratory quality index (RQI) tool described
in the following subsection.
Finally, a possible respiratory rate was derived from each signal by finding
the average period between peaks (the breath-to-breath interval), and thus de-






where ‘BrTBr’ is a breath-to-breath interval, ‘n’ is the number of BrTBr
intervals within the extracted signal, and the ‘signal’ of RRsignal is the PPG-BW,
PPG-AM, PPG-FM, ECG-BW, ECG-AM or ECG-FM.
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4.2.5 Respiratory Quality Assessment
The development of an RQI scheme that assigns each modulation-extracted res-
piratory signal a quality rating on some scale could improve RR estimation al-
gorithms, as knowledge about the quality of each estimated RR can enhance the
networks ability to determine true RR based.
This chapter proposes an efficient and effective RQI scheme that considers
the variance in peak heights (ph), trough depths (td), and the distances between
peak pairs (p-p) and trough pairs (t-t) for any given extracted RR signal.
Consistency is a key indicator of respiratory signal quality, and as such a
metric called the differential coefficient of variation (DCV) metric is developed, a
variation on the the coefficient of variation (CV), to quantify how much variation
is in the signal. The DCV is calculated as follows:
DCV = 1− σ
µ
(4.3)
where σ represents the standard deviation (SD) and µ represents the mean of
the vector of data. The DCV is calculated for each of the four properties of
interest - peak height, trough depths, distance between peak pairs, and distance
between trough pairs. These are denoted as DCVph, DCVtd, DCVp-p and DCVt-t
in Equation (4.4), respectively.
As is shown in Equation (4.4), the RQI is then calculated by finding the
average of the four DCVs.
RQI =
∑ DCV ph +DCV td +DCV p-p +DCV t-t
4
(4.4)
The calculated RQI will be 0 in the case where there is no consistency, and 1
in the case where there is perfect consistency. As consistency is the best indicator
of signal quality, higher RQI values indicate better quality signals.
This scheme was used to calculate an RQI for each of the six modulation-
extracted respiratory signals in every 20-second record; PPG-BW, ECG-BW,
PPG-AM, ECG-AM, PPG-FM, and ECG-FM.
Chapter 4 75
Machine Learning for Non-Invasive Patient Health Monitoring
4.2.6 Feature Selection
Two separate feature vectors are developed to analyse the performance of neural
networks with and without the RQI features as inputs. For the first test, only the




For the second test, the feature vector included RQIs calculated using the
scheme proposed in this chapter, along with the modulation-extracted RRs. The
resultant twelve-feature vector is as follows:
[RQIECG-BW, RRECG-BW, RQIPPG-BW, RRPPG-BW,
RQIECG-AM, RRECG-AM, RQIPPG-AM, RRPPG-AM,
RQIECG-FM, RRECG-FM, RQIPPG-FM, RRPPG-FM, ]
These two feature vectors were constructed for every record that was classified
as ‘good’ by the SQI tool.
4.2.7 Neural Network Structure
In this work, a bidirectional long short-term memory (BiLSTM) network struc-
ture is used to predict respiratory rate from the input features. BiLSTM cells are
updated using the same mathematical structure as unidirectional long short-term
memory cells, but the data is passed through the network both as-is (forwards)
and in reversed order (backwards). The results of these operations is then con-
catenated before passing to the next layer. The mathematical structure of a
single forward or backwards pass is described by the following equations.
c̃t = tanh(wc[ a(t-1), xt] + bc) (4.5)
f t = σ(wf[ a(t-1), xt] + bf) (4.6)
ut = σ(wu[ a(t-1), xt] + bu) (4.7)
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ot = σ(wo[ a(t-1), xt] + bo) (4.8)
ct = ut • c̃t + f t • c(t-1) (4.9)
at = ot • tanh(ct) (4.10)
where , wc, wf, wu and wo refer to the learned weights for their respective op-
erations, while bc, bf, bu and bo are the learned biases. Once again, these are
learnt during training using the Adam optimization algorithm. Additionally, the
parameter a(t-1) refers to the output of the previous layer, while xt is the input
for timestep t. Eqn. (4.9) utilizes the results of (4.5) through (4.7) as well as
the cell state of the previous time step, c(t-1) to update the cell state, and (4.10)
uses the resultant cc as well as the output gate results. The ‘•’ symbol in (4.9)
and (4.10) represents element-wise matrix multiplication.
The neural network structure utilised in this work includes three hidden BiL-
STM layers each comprised of the forward and backwards passes followed by
the concatenation operation. The first two hidden layers return a sequence of
all hidden cell states, hence the high number of concatenation operations. The
third hidden layer outputs only the final state of each cell from both the forward
and backwards pass, and these are then concatenated. The network structure is
illustrated in Fig. 4.5 below.
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Figure 4.5: Structure of the BiLSTM model.
The NN structure included 128 hidden units per hidden layer and a batch
size of 1024 to enable good generalization without overfitting. Adam optimiza-
tion [157] is used to update weights and biases during training, while the mean
absolute error (MAE) is used as the loss function.
4.2.8 Training & Testing the Algorithms
In this work, the NN structure was trained six times to compare the performance
of the network using the six different feature vectors, as follows:
• All 12 features, as calculated from 20-second segments
• The 6 RR features only, as calculated from 20-second segments
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• All 12 features, as calculated from 30-second segments
• The 6 RR features only, as calculated from 30-second segments
• All 12 features, as calculated from 60-second segments
• The 6 RR features only, as calculated from 60-second segments
The data was pseudorandomly shuffled before being split into subsets for
training, validating, and testing. 80% of the data was used for training the NNs,
10% was used for fine-tuning hyperparameters through the validation process,
and the remaining 10% of unseen data was utilized to fairly test the models.
4.3 Results & Discussions
After training and testing all of the NN configurations, statistical and graphical
analysis was conducted to assess the performance of each network. In terms of
statistical analysis, several informative metrics were considered: mean absolute
error (MAE), root mean square error (RMSE), and Pearson’s correlation coeffi-
cient (PCC). Furthermore, Bland Altman analysis was conducted by calculating










20 seconds RR & RQIs 0.821 2.236 0.891 -0.08 8.76
RR Only 1.301 2.776 0.829 -0.16 10.87
30 seconds RR & RQIs 0.747 1.926 0.901 0.14 7.54
RR Only 1.116 2.430 0.839 -0.04 9.53
60 seconds RR & RQIs 0.638 1.575 0.932 -0.15 6.17
RR Only 0.711 1.731 0.919 -0.14 6.79
Table 4.1: Performance of BiLSTM NN using various feature vectors for estimating
respiratory rate
MAE gives key insight into how skilled the network is at producing a reason-
able prediction for RR. RMSE is indicative of how many high-range errors there
Chapter 4 79
Machine Learning for Non-Invasive Patient Health Monitoring
are, and thus provides information about whether the network has fit appropri-
ately to the data. PCC indicates the level of linear correlation, and will give a
result between 0 and ±1, representing no correlation and total positive/negative
correlation respectively.
In terms of the Bland Altman analysis metrics, a low MD along with narrow
LOAs is a good indicator of strong agreement between the two methods of mea-
surement. In Bland Altman analysis, each data point is the result of comparing
the mean of the two measurement methods with the difference between their
predictions. As such, a high-performing network would have low MD and low
LOA width.
The results of calculating these metrics for the BiLSTM NNs trained using
each feature vector are shown in Table 4.1. These results clearly indicate that
the inclusion of RQIs calculated using the proposed scheme greatly improves the
success of machine learning in estimating true RR. Table 4.1 shows that the
inclusion of RQI features reduced the MAE by up to 36.89% when compared to
the equivalent networks that were trained using solely the modulation-extracted
RRs. Significant improvements RMSE and PCC are all also visible across all NN
structures considered. In all cases, including RQI features increased the level of
agreement between true and predicted RR measurements, narrowing the LOA
width. MDs were extremely small across all networks.
Table 4.1 also shows that the BiLSTM network model performs strongly
regardless of the segment length used to derive the RR and RQIs, however MAE
is shown to decrease as segment length is increased. The overall lowest MAE
was 0.638, achieved by the network trained on RRs & RQIs extracted from 60
second segments. As the inclusion of RQI features is shown to reduce MAE, the
remainder of this analysis will focus on the networks trained with both RR &
RQI features.
To further analyse the predictive performance of the BiLSTM network, the
following error histograms were created to graphically investigate the spread of
errors in RR predictions. To create these figures, all errors were rounded to the
nearest 0.25 to allow for better visualisation. These figures reiterate the high
accuracy of the systems trained using both RR and RQI features.
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Figure 4.6: Error Histogram for RR Estimation using RR & RQI features derived
from 20-second PPG & ECG segments.
Figure 4.7: Error Histogram for RR Estimation using RR & RQI features derived
from 30-second PPG & ECG segments.
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Figure 4.8: Error Histogram for RR Estimation using RR & RQI features derived
from 60-second PPG & ECG segments.
The performance of the BiLSTM network is further analysed via the Bland
Altman plots in Figs. 4.9-4.11. Bland Altman plots are used to assess the level
of agreement between two measurement methods - in this case, comparisons are
made between the proposed BiLSTM model against the reference RR measure-
ment from the MIMIC-III database. The difference between the two measure-
ments is plotted against the mean of the two measurements, and as such a high
density around the central ‘mean difference’ line within the ‘limits of agreement’
indicates strong agreement between two schemes. In each plot, the difference vs.
mean results were often extremely close together and appeared to overlap. As
such, a density color scale is included in Figs. 4.9-4.11 to better illustrate the
concentration of points. As can be seen from these plots, there is a high density
of points along the mean difference line, with LOA widths falling below 10 BrPM
for all parameters. This indicates a strong correlation between the true RRs and
those predicted by the proposed network, regardless of the segment length used
for feature extraction.
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Figure 4.9: Bland Altman Plot for RR Estimation using RR & RQI features derived
from 20-second PPG & ECG segments.
Figure 4.10: Bland Altman Plot for RR Estimation using RR & RQI features derived
from 30-second PPG & ECG segments.
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Figure 4.11: Bland Altman Plot for RR Estimation using RR & RQI features derived
from 60-second PPG & ECG segments.
To further assess the correlation between the true and predicted values for
RR, the regression plots in Figs. 4.12-4.14 were constructed. In each figure,
the thick black line represents what ‘perfect’ correlation would look like, while
the dashed black line is the actual correlation achieved by the network. From
this regression plot, it is clear that there is a strong correlation between the
predictions made by the BiLSTM model and the reference RRs obtained from
the MIMIC-III database, regardless of the segment length used to derive the
features. In each plot, the actual correlation line falls very close to the ideal
correlation line, and very few data points are outliers in the trend.
Figure 4.12: Regression Plot for RR Estimation using RR & RQI features derived
from 20-second PPG & ECG segments.
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Figure 4.13: Regression Plot for RR Estimation using RR & RQI features derived
from 30-second PPG & ECG segments.
Figure 4.14: Regression Plot for RR Estimation using RR & RQI features derived
from 60-second PPG & ECG segments.
Overall, the BiLSTM model shows low error and a high level of agreement
with gold-standard measurement, regardless of which segment length is used for
feature extraction. Performance increased as segment length increased, but even
shorter segments showed strong results. In all cases, the inclusion of features
calculated based on the proposed RQI scheme greatly improves the performance
of the BiLSTM neural network. Therefore, it is clear that a BiLSTM model
utilising extracted RRs and the proposed RQIs would significantly improve RR
calculation in clinical and at-home environments, with longer ECG and PPG
segments for feature extraction leading to the most accurate predictions.
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4.3.1 Comparison to Previous Works
The results obtained by the BiLSTM model compares well to previous works
when the feature vectors with both modulation-extracted RRs and corresponding
RQIs were used, regardless of segment length. This is shown in Table 4.2. It is
clear that both models outperform the previous state-of-the-art schemes for RR









Orphanidou [39] 60 1.80 N/A
Karlen [40] 60 N/A 2.3
Birrenkott [43] 32 0.711, 3.122 N/A
Pirhonen [45] N/A 1.764 3.996
BiLSTM + RQI 20 0.821 2.236
BiLSTM + RQI 30 0.747 1.926
BiLSTM + RQI 60 0.638 1.575
Table 4.2: Comparison to previous works
1 Based on testing against 42 Capnobase [164] records
2 Based on testing against 53 records MIMIC-II [165] records
3 Based on testing against 42 Capnobase [164] records, results varied based on window length
selected and on signal used (PPG or ECG)
Compared to the works presented in Table 4.2, the BiLSTM model with RR
and RQI features perform extremely strongly regardless of segment length used
to extract these parameters. The RMSEs of all models were lower than the
previous works in the literature. In terms of MAE, the model trained using 60s
segments outperformed all previous works. One work [43] reported a lower MAE
of 0.71 BrPM on the Capnobase database than was achieved by the proposed
models based on 20s and 30s signal segments, however the MAE of [43] rose to
3.12 BrPM when the scheme was applied to the larger and more comprehensive
MIMIC database. As this chapter is based on MIMIC data, the latter result
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is more comparable. Overall, the BiLSTM model outperforms the literature in
terms of MAE regardless of segment length.
Interestingly, enhanced results were achieved even where the short window
length of 20 seconds was used. Accuracy increased with time, however the risk
of artefacts impacting the signal quality also increases with the length of the
segment. This suggests that the proposed scheme could predict RR faster, while
also achieving a lower error.
It is also worth noting that the previous works largely relied on very small
datasets. Through using a large database for this work, it has been possible to
thoroughly validate the performance of the network across a large and diverse set
of patients. The results presented in this chapter were obtained through training
and testing the proposed schemes on the large and diverse MIMIC-II database,
compared to other recent works such as [43, 45] where 95 and 29 records were
used to obtain the results in Table 4.2, respectively. This ultimately means that
the proposed BiLSTM network with RQI features is more likely to translate to
real-world application with success, while many of the previous works would need
to be validated on larger databases.
4.4 Conclusion
In this work, an RQI scheme was developed to enhance the performance of neural
networks utilizing the respiratory modulations of ECG and PPG signals to esti-
mate true RR. The proposed RQI scheme was implemented and tested to evaluate
improvements in the performance of NNs in predicting RR from modulation-
extracted RR estimates, with exceptional results.
When RQIs were used alongside modulation-extracted RRs as input features,
a bidirectional LSTM model was able to achieve the low MAE of 0.821 BrPM.
This is a significant improvement when compared to other works in the literature,
and proves that RQIs can greatly enhance the performance of neural networks.
The results of this chapter show that a device implementing the proposed
RQI scheme with a BiLSTM NN would be suitable for continuous and non-
invasive monitoring of respiratory rate, using hardware that is already in place
Chapter 4 87
Machine Learning for Non-Invasive Patient Health Monitoring
in many healthcare environments. This algorithm would likely be suitable for
clinical use due to the low error and strong agreement with current gold-standard
measurements. It also offers ease of implementation that is achieved through
utilising sensor data already available in clinical and at-home healthcare settings.
With further validation on persons outside of ICU, it would also be suitable for at-
home health monitoring. This scheme could greatly improve early prediction of
potentially fatal conditions, enhance remote healthcare, and ultimately improve
patient outcomes.
This chapter addresses the research problem of respiratory rate monitoring
that was presented in Section 1.2.1 and provides the third original contribution
listed in Section 1.3. The high performance of LSTM networks in this chapter
further supported their use as part of the hybrid networks used in subsequent
research chapters. Additionally, the development of this scheme alongside the
blood pressure schemes presented in Chapter 3 supports the development of
enhanced diagnostics and prognostics tools. The following chapters therefore
focus on developing prognostics tools that assess mortality risk using only vital
signs and basic demographics.
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Continuous and Automatic Mor-
tality Risk Prediction for Adult
Patients using Vital Signs
This chapter contains material that has been published in the following article:
[2] S. Baker, W. Xiang, and I. Atkinson, “Continuous and Automatic Mor-
tality Risk Prediction using Vital Signs in the Intensive Care Unit: A Hybrid
Neural Network Approach,” Scientific Reports, vol. 10, pp. 21282, December
2020.
5.1 Introduction
Intensive care units (ICUs) treat the most critically ill patients, and as a result
are known to have the highest mortality rate of hospital units [9]. In 2001-2012,
mortality rates across several ICUs in the United States (US) ranged from 11.3%-
12.6% [118]. As such, typical ICUs have high staff-to-patient ratios, and it has
been found that outcomes are improved where there are a higher number of nurses
and consultants per bed [10]. However, providing a high standard of critical care
comes at a cost, with $108 billion spent on critical care medicine in the US in
2010, accounting for 0.72% of gross domestic product (GDP) [166]. The use
of mortality risk assessment tools can aid in resource allocation and treatment
decisions, potentially reducing costs while continuing to provide a high standard
of care to critically ill patients.
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There are several points-based schemes currently used to quantify mortality
risk in ICUs today, including multiple iterations of the Acute Physiology and
Chronic Health Evaluation (APACHE) score and Simplified Acute Physiology
Score (SAPS). While newer versions exist, APACHE-II [119] and SAPS-II [120]
remain the most commonly used mortality risk assessment tools worldwide [122].
Another commonly used tool is the Sequential Organ Failure Assessment (SOFA)
score [121], which was developed to assess sepsis risk but has since been found
to be a relatively good predictor of mortality. Unfortunately, there are several
limitations associated with these tools. Firstly, it has been found that their per-
formance decreases fairly rapidly over time, with Kramer [30] indicating that
SAPS II was out of calibration by 2005. Several subsequent studies have also
identified calibration problems with APACHE, SOFA, and SAPS [123–125]. Cal-
ibration can be lost over time due to changing patient populations and medical
treatments, and typically results in overestimation of mortality [30]. Aside from
the effect of time, Sakr et al. [123] and Lew et al. [125] noted that the schemes
performed poorly for European and Singaporean cohorts, respectively. This in-
dicates that insufficient consideration of diverse patient cohorts has also affected
performance. Aside from calibration issues, these schemes rely on variables that
can be time-consuming and difficult to obtain, such as pathological laboratory
test results and patient medical history.
The limitations of existing scoring systems have lead to a rise in researchers
exploring machine learning techniques for mortality prediction [35, 55–61], as well
as the related issues of predicting the onset of various intervention methods [167,
168] detecting the risk of sepsis [46–48, 126] and other clinical deterioration events
[49, 50]. Machine learning approaches have the advantage of being relatively easy
to continuously update and recalibrate, with algorithms able to be configured in a
way that enables continuous training based on new data obtained while it is being
used in clinical environments. This in turn enables machine learning techniques
to better generalise to current local or global populations, even as treatments and
outcomes change with time. A recurring theme in these papers is a dependence
on features including complex laboratory results, existing health conditions, and
other patient history. Of the aforementioned studies that consider mortality
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risk prediction, the majority depend heavily upon laboratory results [35, 56–60],
which include values obtained from extensive blood, urine, breath, and other
clinical analysis, and are often complex and time-consuming to obtain and then
enter in patient’s medical records.
A common metric for assessing the discrimination performance of diagnostic
tools is the area under the receiver-operator curve (AUROC). In terms of this
metric, the highest performing mortality prediction systems were presented by
Johnson et al. [59] and Delehanty et al. [60] with AUROCs of 0.927 and 0.94,
respectively. However, the system presented by Johnson et al. [59] is dependent
on 148 features comprised predominantly of complex laboratory results. This
limits the usefulness of the system, as medical staff would need to measure and
enter a massive number of variables to receive an accurate prediction.
Meanwhile, in the work presented by Delahanty et al. [60], only 17 variables
were used - however, over 50% of the decision made by their system is based
on All Patients Refined Diagnosis Related Groups (APR-DRG) risk of mortality
and severity of illness, as well as Glasgow Coma Score (GCS), and the cost-
weight index based on Medicare Diagnosis Risk Groups (MS-DRG). In short,
this system depends heavily on diagnoses being made manually by doctors based
on data available close to the time of ICU admission. This introduces potentially
heavy human bias, and would not be functional for hospitals where the APR-
DRG and MS-DRG diagnosis coding schemes aren’t used.
Conversely, Deliberato et al. [55] investigated the use of features extracted
from only vital signs, achieving a relatively low AUROC of 0.65, indicating low
ability to distinguish between mortality and non-mortality cases. The authors
also considered using vital signs in combination with other parameters, achieving
a much higher AUROC of 0.84 when vitals data was combined with the GCS,
SAPS-II score, patient demographics and information obtained about the patient
during their hospital stay prior to ICU admission. This is certainly an improved
performance; however it depends upon significant lab results and data from pre-
admission. It would be preferable to use only vital signs and basic demographics,
but with much higher performance than the 0.65 AUROC achieved by this work.
Another common theme in the literature is that of mortality prediction at
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admission. While there are advantages of early mortality risk prediction, this
method is inflexible and does not consider how a patient might respond to treat-
ments after ICU admission. This was identified in a recent work by K. Yu et
al. [61], where a bidirectional long short-term memory network was trained on
multiple windows to identify mortality risk at any given time. This scheme uses
the same features such as the SAPS-II score, which includes many laboratory
values, GCS, demographic information, admission type, and comorbidities. As
such, laboratory measurements would need to be repeated regularly for the sys-
tem to predict effectively. Additionally, it requires 48 hours of data to predict
future mortality risk effectively.
In the literature, there are many machine learning (ML) techniques consid-
ered for prediction of mortality. However, there have been relatively few that
investigate the use of neural networks (NNs) specifically. Early works investi-
gating NNs for mortality prediction focused on simple feed-forward neural net-
works [128–130], achieving comparable performance to scoring schemes such as
APACHE. Works in recent years have begun to focus on NNs that are more
advanced, such as long short-term memory (LSTM) NNs and convolutional NNs
(CNNs). Several works [56, 61, 131] have identified long short-term memory
(LSTM) networks as candidates for mortality prediction. LSTM has also proven
successful in predicting septic shock [46] and other clinical deterioration events
[50]. The primary advantage of LSTM is that it has the ability to ‘remember’
information that it has already seen, allowing it to identify relationships between
different variables within the sequence.
Meanwhile, convolutional neural networks (CNNs) have also proven powerful
in solving many medical problems such as detecting heart anomalies [51–53],
identifying variations in Korotkoff sounds [54] and gait detection [169]. CNNs are
exceptional at identifying the importance of certain features with respect to one
another, and thus adding CNN layers prior to LSTM layers can greatly improve
the predictive ability compared to pure LSTM. This was attempted by Alvis et
al. [57], with their scheme achieving an AUROC of 0.836 when predicting ICU
mortality from a 48-hour window of features including vital signs and laboratory
values. This strongly suggests that a well-designed CNN-LSTM network would
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be a good candidate for mortality prediction, combining the benefits of both
network types for a resultant network that can identify important variables and
any relationships that exist between them.
Aside from the model itself, another critical factor in the success of a neural
network is the selection of features. To develop a system that could automati-
cally update mortality risk throughout a patient’s stay, it is essential to choose
features that are both meaningful and easy to measure, ideally without any man-
ual measurement. One recent work by Giannini et al. [126] considered hundreds
of features for predicting septic shock, a strong risk factor for mortality. In a
retrospective analysis, the authors found that 10 out of 20 of the most impor-
tant features were derived from vital signs, while another was age. This finding
is significant but largely unsurprising, given vital signs measure the most crit-
ical functions of the human body [127]. Fortunately, vital signs are regularly
recorded, either through automatic measurements or regular manual measure-
ments. These advantages mean that vital signs and statistics derived from them
are ideal features for use in mortality prediction.
Another important factor in the real-world success of a NN for medical pre-
diction problems is the adoption of clinicians. In recent years, many studies
have identified the need for artificial intelligence to be interpretable, especially
for healthcare applications [170–173]. Primarily, interpretability involves making
the system easier to understand and therefore to trust. There are many ways to
achieve this, including selecting features that are simple to understand from the
perspective of domain experts [172].
As such, this chapter aims to develop a neural network approach for mor-
tality using straightforward features with clear ties to patient health. Our work
contributes to the literature through the development of the novel Artificial In-
telligence Mortality Score (AIMS) scheme, a mortality risk classifier based on a
hybridized CNN-LSTM network that uses only age, gender, and statistical pa-
rameters derived from a 24-hour window of vital sign measurements as features.
AIMS is capable of continuously-updating prediction of the risk of mortality
within 3-day, 7-day, and 14-day windows. Much of the previous literature fo-
cuses on predicting mortality events within the entire stay [57–60], however the
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average length of stay in ICU in America is only 3.8 days [166]. Our analysis of
the patients from the MIMIC-III database who met our selection criteria revealed
that 65% of patients stayed in ICU for ≤ 3 days, 87% for ≤ 7 days, and 95% for
≤ 14 days. The models in the literature that focus on the entire stay would likely
form a bias towards data obtained from shorter stays, given that these form the
majority of cases. This in turn introduces the risk that models would not per-
form as well on longer-term patients. However, mortality risk assessment needs
to be reliable for even the longest staying patients to ensure that they receive the
appropriate care should they begin to stabilize or deteriorate. As our selection
of 3-day, 7-day and 14-day windows encompasses the entire stay for the majority
of patients, it enables fair comparison to the literature. In clinical practice, it
offers the clear advantage of predicting risk within a clear time frame, with the
score able to be easily and continuously recalculated continuously throughout the
stay so that mortality risk is able to be quantified for all patients at all times,
including for those with longer stays in ICU.
The remainder of this chapter is structured as follows; Section 5.2. describes
the methodology used for extracting and processing data from the MIMIC-III
database, as well as the structure of the AIMS network. Section 5.3. presents
results and discussion, including comparison to currently used schemes and other
novel schemes in the literature. Finally, Section 5.4. concludes the chapter and
presents recommendations for future work.
5.2 Methodology
5.2.1 Selection of Data
The large amount of data used in this work was obtained from the Medical
Information Mart for Intensive Care (MIMIC-III) clinical database [151]. The
MIMIC-III database is comprised of deidentified data from over 60,000 ICU stays,
including both adult and neonatal patients.
This study focuses on adult patients admitted to ICU for any reason, and thus
the only criterion when selecting patient records was that the patient must be
≥18 years old. To be able to extract data for 3-day, 7-day, and 14-day mortality
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risk prediction, we obtained a 14-day window for each patient. Our method for
selecting data is outlined as follows:
• Where the patient survived their ICU stay, and their stay exceeded 14 days,
the first 14 days of data after ICU admission were obtained;
• Where the patient died during their ICU stay, and their stay exceeded 14
days in length, the 14 days of data prior to their death time were obtained;
• Where the patient stay was shorter than 14 days, all data from ICU ad-
mission to discharge from ICU were obtained.
For all patients, some fundamental information was recorded during the data
selection process - namely their age, gender, and time of death where applicable.
The events that were obtained from the database for our AIMS scheme were
the heart rate (HR), systolic BP (SBP), diastolic BP (DBP), mean arterial pres-
sure (MAP), respiratory rate (RR), blood oxygen levels (SpO2), and temperature.
All events matching this description were obtained, as our AIMS scheme depends
upon statistical analysis of the variation of events such as HR and temperature.
Vital signs were chosen as features for two main reasons: interpretability, and
ease of measurement in the ICU. Vital signs are the most fundamental indica-
tor of health, and are readily understood by all healthcare professionals. Most
vital signs are easily measured using non-invasive equipment, enabling contin-
uous measurement and thus data streams rich with information. Perhaps the
most challenging to measure are BP and RR, with continuous methods currently
either invasive or uncomfortable. However, recent research in measuring these
parameters has focused on non-invasive, continuous methods [1], and as such it
is likely that data streams for BP and RR measurement will become increas-
ingly data rich as this technology is adopted into clinical practice. Richer data
streams enable better quantification of the variability of vital signs, and thus
would further improve the predictive performance of our network.
5.2.2 Feature Selection
For the development of our AIMS scheme, features were selected or derived from
the commonly recorded parameters in the ICU. The first two features selected
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are those that provide basic information about the patient: their age and gender.
Age is recorded in years as an integer, while gender is recorded as a binary value
where ‘1’ and ‘0’ represent female and male patients, respectively.
All other features selected were chosen to represent the vital signs of interest
- HR, SBP, DBP, MAP, RR, SpO2 and temperature. These parameters were
regularly recorded in the MIMIC-III database, however the recording was often
inconsistent with the frequency of measurement varying throughout the patient’s
stay. This resulted in highly variant quantities of data available for different
patients. However, it has previously been shown that trends in vital signs can
assist in identification of clinical deterioration in hospital settings [174]. As such,
we apply statistical analysis to quantify the variability of each vital sign over
the 24-hour window. This has the benefit of representing the inconsistent data
within the database in a consistent manner, and also has the secondary benefit
of improved computational efficiency.
We limit the acquisition window to 24 hours to ensure that the network is
considering the patient’s current health status. In our own experimentation,
narrower windows reduced performance, while broader windows of 48 hours did
not significantly improve performance. Additionally, if a wider window were used
then the network may be prone to under- or over-estimating the severity of the
patient’s current condition based on their previous condition. For example, if all
data from admission onward were used, then the patient might remain relatively
stable for the first 9 days of their stay before showing signs of deterioration on
the 10th day. If a risk window from admission onward was used, then overall
the variation in the patients health would appear low, and thus the deterioration
may not be noticed. Similarly, a patient who is highly unstable at the start of the
admission but stabilises as a result of treatment might incorrectly be identified
as a mortality risk. Considering a 24-hour risk window avoids this problem, as
AIMS could be regularly and automatically recalculated throughout the entire
stay, and thus would be more capable of identifying deterioration or stabilisation
during long stays.
From the 24-hour window, the first and last values were taken to indicate how
the vital sign changed from the beginning to the end of the window, while the
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minimum and maximum values were recorded to show the most extreme events
during the window. Mean and median were both chosen to provide an accurate
representation of the average event for the vital sign - the use of both helps
to reduce the risk of unusual data distribution skewing the result. Finally, the
standard deviation (STD) is used to quantify the variability of the events for that
vital sign. Where any result was NaN, it was replaced with a ‘numerical NaN’
chosen to be the extremely negative value of -999. If more than two vital signs
were completely absent from a patient’s records, then that record was discarded
and not used for training or testing of the AIMS model.
After extracting the relevant data, the final feature array included the funda-
mental patient information, as well as the variability statistics for each vital sign.
This resulted in a total of 51 features, including age, gender, and 7 statistical
features for each of the 7 vital signs.
Our model was trained to predict three different cases; risks of mortality
within 3 days, 7 days, and 14 days respectively. These models are hereafter
referred to as AIMS-3, AIMS-7 and AIMS-14 respectively. These windows were
selected to consider both immediate mortality risk, and longer term mortality
risk. The feature vectors for risk of mortality within 3-day, 7-day and 14-day,
risk windows considered the same features, however they were calculated from
varying 24-hour windows in each case.
Where the patient survived their ICU stay, the relevant 24-hour window used
for training and testing the model was always the first 24 hours after admission.
Where the patient did die, the 24-hour window selected was dependent on the
length of their stay. Where the patient died within less than the 3-day, 7-day, or
14-day risk period, the first 24 hours of data post-admission were used. Where
their death occurred after a longer stay than the risk window, then their time of
death was set as the end time, and the 24-hour prediction window was chosen
to start from (end time - size of the risk window). For example, where 3-day
mortality risk was considered, the death time would be set as ‘72 hours’. Then,
72 hours prior to death would be chosen as relative 0, with the prediction window
thereafter being data recorded between hours 0 to 24.
After data and feature selection, there were 3 distinct cohorts. This was
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largely as a result of inconsistencies in data richness, with certain variables not
recorded for some patients in different windows. This lead to some patients
having data available for one or two risk windows, but not the remainder. The
cohorts for AIMS-3, AIMS-7, and AIMS-14 are illustrated in Tables 1-3 below.
Ages have been clustered by ranges, as ages exceeding 89 in the MIMIC-III
database were set to values exceeding 300 for de-identification purposes [151].







Female 22415 (43.71%) 19888 (43.36%) 2527 (46.66%)
Age (Years)
18-39 4896 (9.55%) 4687 (10.22%) 209 (3.86%)
40-59 14204 (27.70%) 13147 (28.67%) 1057 (19.52%)
60-79 21230 (41.40%) 19040 (41.51%) 2190 (40.44%)
≥ 80 10949 (21.35%) 8989 (19.60%) 1960 (36.19%)







Female 22483 (43.69%) 19888 (43.36%) 2595 (46.41%)
Age (Years)
18-39 4906 (9.53%) 4687 (10.22%) 219 (3.92%)
40-59 14244 (27.68%) 13147 (28.67%) 1097 (19.62%)
60-79 21305 (41.41%) 19040 (41.51%) 2265 (40.50%)
≥ 80 11000 (21.38%) 8989 (19.60%) 2011 (35.96%)
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Female 22560 (43.69%) 19888 (43.36%) 2672 (46.41%)
Age (Years)
18-39 4916 (9.52%) 4687 (10.22%) 229 (3.96%)
40-59 14282 (27.66%) 13147 (28.67%) 1135 (19.65%)
60-79 21397 (41.44%) 19040 (41.51%) 2357 (40.81%)
≥ 80 11044 (21.39%) 8989 (19.60%) 2055 (35.58%)
5.2.3 Neural Network Structure
Hybrid NNs offer the advantages of multiple standard NN types. In this ap-
plication, we develop a hybridized CNN-LSTM network, as shown in Fig. 5.1.
CNNs are widely used to identify patterns and important features, while LSTM
networks are known for their “memory”, which enables them to remember which
information in a sequence is the most important. Combining the two network
structures results in a powerful hybrid NN with strong pattern and sequence
recognition abilities, which is highly beneficial in an application where patterns
and feature importances are not easily identified.
Figure 5.1: AIMS network structure.
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As shown in Fig. 5.1, our network includes two temporal (one-dimensional)
CNN layers with 128 hidden units each. Both CNN layers utilize rectified linear
unit (ReLU) activation, described mathematically as
relu(z) = max(0, z) (5.1)






i ∗ xm(i-1) + bji) (5.2)
where yij represents the output jth feature map of the ith layer. Convolution
is indicated by the ∗ symbol. Weights are denoted using the term wjni, which
describes the nth weight of the jth feature map from the (i− 1)th layer, where
n = 1, ..., N . The parameter xm
(i-1) represents the outputs of the (i− 1)th layer,
and finally bj is the jth bias term of the ith layer. Weight and bias terms are
all initialized to zero and updated using the Adam optimization algorithm [157]
throughout training.
Temporal average pooling layers with a pool size of 2 and a stride size of
2 follow each of the CNN layers. This operation sweeps through the output of
the CNN layers, taking the average of each pool it sees and outputting that
value. Effectively, this downsamples the data by a factor of 2, helping prevent
overfitting of the network. Average pooling layers are denoted in Fig. 5.1 as
AvgPool-1 and AvgPool-2, respectively.
A bidirectional LSTM layer with 128 hidden units follows the final temporal
average pooling layer. Bidirectional LSTMs (BiLSTMs) have the same mathe-
matical structure as unidirectional LSTMs, but data is passed through the net-
work in both the original and reversed orders. This allows for learning from both
past and future values in the sequence. The results of both the forward and re-
versed passes are then concatenated to form the final output. The mathematical
theory of LSTM networks is described by Hochreiter et al. [175].
The final layer of our AIMS network is a simple densely-connected unit uti-
lizing sigmoid activation, which outputs a value between 0-1. If the result is <
0.5, the network predicts that the patient will survive. Conversely, if the result
is ≥ 0.5, the network predicts that the patient will die. The further away from
100 Chapter 5
Machine Learning for Non-Invasive Patient Health Monitoring
0.5 the output is, the more confident the network is in its prediction, and higher
confidence typically corresponds with higher accuracy.
For the purposes of training and testing the performance of AIMS, thresholds
are used to predict either ‘mortality’ or ‘no mortality’. However, in terms of
interpreting this result in a clinical sense, the overall prediction of ‘mortality’ or
‘no mortality’ could be provided alongside a confidence metric that indicates how
certain the neural network was of its prediction. The raw 0-1 value outputted by
the final layer of the network indicates the level of confidence the network has in
its prediction. This confidence metric could be modified for easier understanding





Using this equation, a score of 0.14 would be interpreted as ‘no mortality -
72% confident’ while a score of 0.78 would be interpreted as ‘mortality - 56%
confident’. This easy-to-understand strategy would further increase the likeli-
hood that clinicians would trust the model, as they would be able to better
understand the severity of the patient’s condition and it would be clearer that
AIMS is not simply making binary decisions with full confidence. This metric
would also give clinicians more insight into the path of treatment that would be
most appropriate. For example, a patient who was predicted as ‘mortality - 96%
confident’ may require more rapid and extreme treatment than a patient who
was predicted as ‘mortality - 2% confident’; effectively on the cusp of the two
prediction classes.
5.2.4 Training & Testing the Algorithms
To train and test the proposed AIMS network, we used stratified k-fold cross-
validation with 10 folds. Using this method, the data is split in 10 different ways,
with all data being used as the testing set during one fold. Stratification ensures
that each class is represented roughly equally in all splits. Cross-validation using
k-fold gives a more realistic idea of the performance of a network.
After preprocessing, records from 51,279 unique patient stays were available
for use in training and testing AIMS-3. There were slightly higher record numbers
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of 51,455 and 51,639 for AIMS-7 and AIMS-14 respectively. The slight differences
in record numbers are caused by a higher degree of missingness in some windows,
leading to more data that was excluded in those cases. As we were using 10 folds
for cross validation, 10% of the data was used for testing purposes and thus
was unseen to the model for that fold. A further 80% of the data was used as
the training set for AIMS, while the final 10% was used for validation, which
improves fine-tuning of hyperparameters and allows for assessment of the “best”
model during training.
The data available for this task was highly unbalanced, with mortality events
only occurring in up to 11.19% of cases. To ensure that the model did not achieve
high accuracy simply by overfitting to the majority class, a weighting of 9 was
placed on the importance of learning the minority case. This value is reflective of
the mortality rate within the ICUs included in the MIMIC-III database; it was
chosen based on the fact that there were approximately 9 non-mortality cases to
each mortality case within each cohort. This weighting ensured that the network
considered the two classes to be equally important, and placed approximately
equal emphasis on accurately predicting both mortality and survival. If the
network is to be trained on an ongoing basis in the future, this weighting may
need to be adjusted based on the mortality rates within the training set of data,
but this could be done programmatically.
For each fold, the AIMS model was trained over 100 epochs with a batch size
of 1024. These values were found to be optimal for ensuring that the model is
capable of generalizing well, rather than overfitting to the training data. Binary
crossentropy was used as the loss function, due to its clear suitability for this
binary classification problem. For each fold, the “best” model weights were
determined to be those that resulted in the lowest validation set loss during the
100 epochs of training; these weights were saved and used to test the model.
The loss function used was binary cross-entropy, due to the binary classification
nature of the model.
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(a) AIMS-3 (b) AIMS-7 (c) AIMS-14
Figure 5.2: Average ROC and ROC of each fold for 10-fold cross validation.
5.3 Results & Discussions
Following the training and testing of AIMS-3, AIMS-7 and AIMS-14 with 10-
fold cross-validation, an extensive statistical analysis was conducted to assess the
performance. The most commonly used metric in assessing the performance of
a diagnostic tool is AUROC, which plots the true positive rate against the false
positive rate. Figs. (5.2a-5.2c) illustrate the receiver-operator curves (ROCs)
for each of the trained networks. It is clear from these figures that the ROC
curve is highly consistent across all 10 folds, with none deviating far from the
calculated average. This cross-validation confirms that the results obtained from
the AIMS-3, AIMS-7, and AIMS-14 models are a realistic representation of how
the network would perform in reality.
Fig. 5.3 further illustrates the differences between the ROC curves for the
three networks. As can be observed from this figure, the AIMS-3 model achieves
the highest AUROC, followed by AIMS-7 and then AIMS-14. This is a largely
unsurprising result as AIMS-3 predicts the risk of death within the shortest
window of 3 days. However, this figure also clearly demonstrates that all three
models have high AUROC, meaning that they are able to distinguish between
mortality and non-mortality cases very well.
A numerical summary of the AUROC results obtained across the 10-fold
cross-validation of each model is presented in Table 5.4. This table highlights
the minimum, maximum, and average AUROC obtained across the 10 folds when
training each of the three models. These values again indicate the strong consis-
tency across all 10 folds of cross-validation, further suggesting that this model
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Figure 5.3: Comparison of ROCs for all AIMS schemes
is realistic and suitable for use as a diagnostic tool. The highest variance in
AUROCs across folds is seen in AIMS-14, which is to be expected given that
accurate prediction becomes more challenging across longer windows. However,
the variance is still very low and all folds achieved strong AUROC values.
Table 5.4: AUROC statistics over 10 folds
Model AUROC
Minimum Average Maximum
AIMS-3 0.8741 0.8835 0.8926
AIMS-7 0.8587 0.8619 0.8676
AIMS-14 0.8399 0.8577 0.8826
An alternative metric to the AUROC considered by some works in previous
literature is the area under the precision-recall curve (AUPRC). This metric can
be useful where data is imbalanced, as it was within our chosen database. Fig.
5.4 illustrates the precision-recall curves (PRCs) for each of the AIMS schemes.
As is evident in Fig. 5.4, each of the AIMS models performs strongly and is well
above the baseline. Once again, we see that AIMS-3 has the best curve, achieving
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Figure 5.4: Comparison of PRCs for all AIMS schemes.
an average AUPRC of 0.5973 across 10 folds. Meanwhile AIMS-7 and AIMS-14
achieve AUPRCs of 0.5529 and 0.5487, respectively. This again indicates that
there is more certainty regarding mortality risk prediction for smaller windows
of time.
Other features that are important for any classification problem are accuracy
(ACC), specificity or true negative rate (TNR), and sensitivity or true positive
rate (TPR). ACC, TNR and TPR provide insight into the overall accuracy, the
accuracy for the negative class, and the accuracy for the positive class, respec-
tively. We summarise these parameters, as well as those of AUROC and AUPRC,
in Table 5.5. Each of the presented value is the average, taken across the 10 folds
of cross-validation.
Table 5.5: Results obtained by AIMS
Model ACC (%) TNR TPR AUROC AUPRC
AIMS-3 80.07 0.802 0.792 0.884 0.597
AIMS-7 77.07 0.770 0.780 0.862 0.553
AIMS-14 76.22 0.765 0.779 0.858 0.549
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Table 5.5 clearly shows that each of the networks achieves high accuracy.
High accuracy alone cannot be used to assess the results where data is so heavily
imbalanced, so sensitivity (TPR) and specificity (TNR) are also considered. Both
of these parameters are measured between 0-1. High sensitivity and specificity
indicate the ability of the network to correctly predict the mortality and non-
mortality events, respectively. For each of the AIMS models, TPR and TNR
are nearly equal, indicating that they can predict both the mortality and non-
mortality cases with similar accuracy. Once again, AIMS-3 performs best in all
categories, but AIMS-7 and AIMS-14 still show strong performance despite their
longer prediction window.
5.3.1 Comparison to Previous Works
After performing thorough statistical analysis on AIMS-3, AIMS-7 and AIMS-14,
we now consider how these networks perform compared to other state-of-the-art
systems presented in the literature. The comprehensive Table 5.6 compares our
three AIMS schemes to schemes presented by several recent papers. Unfor-
tunately, many papers only presented AUROC, but where other metrics were
available we have included these for comparison also. Accuracy and TNR have
not been included, as these have unfortunately not been presented in any of the
works we consider.
We include columns presenting the number of features, measurement window,
and description of features. The description of features column is used to broadly
explain what types of features were used by each network. ‘Vital signs’ refers
to raw vital signs and any statistics derived from them, ‘GCS’ is the manually
determined Glasgow Coma Score, ‘demographics’ refers to information about
the patient’s background, ‘comorbidities’ are existing diagnosed conditions, and
‘medications’ are those administered during the ICU stay. ‘Laboratory results’
refers to results obtained from blood, urine, and other laboratory analysis, in-
cluding but not limited to: bilirubin, creatinine, hematocrit, blood urea nitrogen,
white blood cell count, and many more.
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Our AIMS-3 and AIMS-7 networks exceed the performance of all other schemes
except those presented by Johnson et al. [59], Delahanty et al. [60], Thorsen-
Meyer et al. [131], and K. Yu et al. [61] in all measured metrics. Compared to
the scheme presented by K. Yu et al. [61], our AIMS-3 scheme achieves an AU-
ROC that is less than 0.002 lower, while AIMS-7 and AIMS-14 achieve slightly
lower AUROCs. However, our models perform much more strongly in terms of
the AUPRC. This indicates that our models have far stronger precision and re-
call, which in turn indicates a higher accuracy, and stronger performance on the
mortality event class. Additionally, our scheme depends on far simpler features
that are easily interpreted by the user.
The model proposed by Thorsen-Meyer et al. [131] for 90-day mortality from
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admission time was based on iterative improvement to the measurement through-
out the hospital stay. It is based on the same features as SAPS-III, with these
features recalculated every hour and used to update the model’s prediction. At
admission, the AUROC was at its lowest - 0.73. This then steadily increased
throughout the stay, with AUROC reaching 0.82 after 24 hours, then 0.85 after
72 hours, and finally 0.88 at the time of discharge from ICU. This is an inter-
esting approach for long-term mortality prediction, however it differs from our
own scheme in several ways. Firstly, our scheme provides mortality risk predic-
tion within shorter windows, which is more suitable for supporting immediate
treatment decisions. Accurate prediction of 90-day mortality is certainly com-
mendable, but the width of the window would limit the usefulness in making
treatment decisions during a patient’s stay. Secondly, the dependence of the
Thorsen-Meyer et al. model [131] on SAPS-III parameters introduces a higher
burden on healthcare workers, with a number of pathological tests needing to
be constantly re-run to keep this information up-to-date. Our scheme uses only
vital signs, which are simple to record even without automatic equipment. As
such, our scheme would place less additional burden on healthcare providers and
would be more suitable for low-resource hospitals. Finally, the Thorsen-Meyer
et al. model [131] has substantially lower AUROC during the early stages of
admission, reaching only 0.82 with 24 hours of data. All three of our AIMS
schemes achieve a higher AUROC using 24 hours of data. Furthermore, within
24 hours our AIMS-3 scheme achieves a marginally better AUROC than that of
the Thorsen-Meyer et al. model [131] at time of discharge. Overall, the AIMS
scheme would be more suitable for short-term mortality prediction in ICU envi-
ronments.
The AUROC of our strongest network, AIMS-3, also compares favourably
to the high-performing scheme presented by Johnson et al. [59]. Unfortunately
there are no other metrics presented in this paper to which we can compare.
However, it is clear that this model depends on a feature vector nearly three
times larger than our own. Additionally, the feature vector used by Johnson
et al. [59] depended heavily upon laboratory values. Of the 148 variables con-
sidered, only 20 were vital signs - the rest were the results of laboratory tests
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and the GCS. As such, it would be extremely difficult to implement this scheme
in reality, and even more challenging to update it regularly during the stay, as
medical professionals would have to undertake the laborious task of extensive
data entry. Meanwhile, our scheme depends primarily on vital signs that are ei-
ther automatically recorded or manually measured simply and regularly, greatly
reducing the demand on healthcare workers.
Minimal statistics were presented by Delahanty et al. [60], but they do achieve
the highest AUROC of the papers we consider. Unfortunately, it has many limi-
tations. While it depends on 17 features directly, three of those features are based
on manual diagnosis. As previously discussed, the APR-DRG Risk of Mortality
and APR-DRG Severity of Illness are determined based on the diagnosis of the
patient, which requires that all diagnoses are known, and also that the hospital
uses this particular coding scheme. The scheme also demonstrated strong depen-
dency on MS-DRG codes to determine the Medicare cost-weight index, and these
codes are certainly not used in all hospitals. Despite depending on 17 features
directly, the dependency of the scheme presented by Delahanty et al. [60] on
these 3 diagnoses-based features means that there is a much greater true depen-
dence based on the many parameters that are used to determine the diagnosis.
Additionally, the scheme presented Delahanty et al. [60] depends on a 48-hour
window including 24 hours pre-ICU admission and 24 hours following admission.
Therefore, it could not be used in any window other than at ICU admission, and
would likely not perform well where the patient is admitted directly to ICU with-
out having first stayed elsewhere in the hospital. Conversely, our AIMS schemes
depend on just 24 hours of data, and can be easily and automatically updated
throughout the patient’s stay.
Overall, our AIMS schemes - particularly AIMS-3 - perform strongly as op-
posed to the comparative schemes in the literature. Two papers - those by
Johnson et al. [59] and Delahanty et al. [60] achieved higher AUROC, but pre-
sented no other statistics. Additionally, there are strong limiting factors that
would prevent their adoption into healthcare environments. Meanwhile, our
AIMS networks depend solely upon statistics derived from vital signs and two
simple demographics - age and gender. These parameters are regularly recorded
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in ICUs, often automatically. Additionally, the selection of vital signs as parame-
ters would ensure that even low-resource healthcare environments would be able
to utilise our scheme. The ease of measurement would also be extremely valuable
in times of crises where a high number of patients may be admitted to intensive
care, such as following a natural disaster or during a pandemic like COVID-19.
Other schemes in the literature that rely on time-consuming and laborious col-
lection of pathology results and/or patient histories would place high burden on
an already strained system, making them challenging and impractical to use in
such situations.
Our AIMS models also have the advantage of being easy to calculate in any
24-hour window due to the regular and often continuous recording of vital signs.
This is a significant advantage over other schemes that have only considered cal-
culation of mortality during a single window immediately following admission.
We therefore conclude that our scheme is a strong candidate for predicting real-
time mortality in ICU environments, however we acknowledge that this study
has been conducted retrospectively on a single popular ICU database. We aim
to further verify the performance of AIMS through clinical trials, with the aim
of ensuring that it will perform as strongly on other patient populations. Fur-
ther improvements will be made as necessary to ensure that the AIMS scheme
performs equally well across all populations.
5.4 Conclusion
In this chapter, we have presented AIMS, a hybrid neural network structure that
combines temporal convolution layers with long short-term memory layers. We
have then trained and tested three instances of AIMS: AIMS-3, AIMS-7, and
AIMS-14, which predict the risk of a mortality event within the following 3, 7,
and 14 days, respectively.
AIMS-3 was the highest performing instance of the network, however AIMS-7
and AIMS-14 also perform strongly and compare well to other schemes in the
literature. All three schemes could be used simultaneously in hospitals, giving
healthcare workers a clear picture of both short-term and longer-term mortality
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risk to the patient.
The AIMS scheme is dependent only on age, gender, and statistics derived
from vital signs. These features are all readily and regularly recorded in ICU
environments, with minimal effort required by healthcare workers. The simplic-
ity of the features chosen also ensures that AIMS could be recalculated on a
continuous and automatic basis during a patient’s stay. This would provide in-
valuable information about whether a patient is responding to treatment or not,
thus allowing medical professionals to modify their treatment plan more readily.
Furthermore, the simplicity of both inputs and outputs to AIMS improves the in-
terpretability of the overall model, thus improving the likelihood that healthcare
providers would place their trust in its predictions.
One limiting factor for this work was that the MIMIC-III records for indi-
vidual patients are not equally data-rich for all windows considered. This leads
to some patients being included in the cohort for one or two schemes, but not
the remainder. In turn, this prevented robust analysis of stability between the
systems - that is, analysis of how similar the predictions of AIMS-3, AIMS-7,
and AIMS-14 were for a single patient. We aim to address this in the clinical
trial phase, where we will be able to ensure that data is recorded with consistent
frequency throughout trials.
Overall, AIMS is an easy-to-interpret and powerful tool for mortality risk
prediction in the ICU. The results presented in this chapter indicate that the
three AIMS networks may be suitable for clinical implementation. In our own
future works, we aim to conduct clinical trials using the AIMS networks to further
analyse and improve upon its performance. We will also seek to assess the
interpretability of the system during the clinical trial process, improving upon it
as necessary.
The AIMS scheme addresses the research problem of mortality risk assess-
ment in adults, as described in Section 1.2.3. It leads to the fourth original
contribution of this work. Furthermore, this chapter shows that vital signs can
be used to predict mortality risk, which informed the feature selection and overall
methodology of the following and final research chapter.
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Non-invasive and Continuous Neona-
tal Mortality Risk Assessment us-
ing Respiratory and Heart Rate
Variations
This chapter extends upon the adult mortality risk prediction scheme presented
in Chapter 6, developing a neural network technique for mortality risk prediction
in neonatal patients. A separate risk prediction scheme is necessary for this
group, as ‘normal’ health parameters differ greatly between newborns and adults.
The scheme presented in this chapter quantifies mortality risk for neonates using
fewer vital signs and alternative age demographics that quantify the prematurity
of the infant.
This chapter contains materials included in the following manuscript, which
has been submitted to Computers in Biology and Medicine
[5] S. Baker, W. Xiang, and I. Atkinson, “Non-invasive and Continuous
Neonatal Mortality Risk Assessment using Respiratory Rate and Heart Rate,”
in revisions with Computers in Biology and Medicine.
6.1 Introduction
Complications resulting from premature birth are the leading cause of death in
children under 5 [132], and over 50% of neonatal deaths occur in preterm infants
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[176]. Child deaths due to preterm birth are in excess of 1.1 million per year
globally [133]. Recent data shows that preterm birth rates are increasing in 62
of the 65 countries with reliable trend data, indicating that this is a growing
problem throughout the world.
Preterm infants are regularly cared for in Neonatal Intensive Care Units
(NICUs). A recent study in the United States found that 84.41% of very low
birthweight infants (those weighing 500-1499 g) and 41.18% of low birthweight
infants (those weighing 1500-2499 g) are admitted to NICU, respectively [177]. In
the NICU, assessment of mortality risk assists medical specialists in making diffi-
cult decisions regarding which treatments should be used and when, and whether
initiated treatments are working effectively. It has been identified that precise
mortality prediction would ease the process of making such decisions [178].
Currently, there are several scoring schemes used in NICUs for mortality
risk assessment. One commonly used score is the updated Clinical Risk Index
for Babies (CRIB-II) [134], which is a recalibrated and simplified iteration of
the original CRIB score [135]. Another family of scores that are routinely used
are the Score for Neonatal Acute Physiology (SNAP) [137] and it’s derivatives,
which include the expanded SNAP Perinatal Expansion (SNAPPE) [136], and
the simplified versions of SNAP-II and SNAPPE-II [179]. The Berlin score [138]
and Neonatal Mortality Prognostic Index (NMPI) [139] are also used, albeit to
a lesser extent.
There are several limitations with the existing scores. Firstly, all aforemen-
tioned scores include parameters that require complex manual measurement.
CRIB-II is the simplest and relies on just five parameters, however one of these
is base excess. The small number of variables is good for quick calculation, how-
ever may limit the ability of the CRIB-II score to identify response to treatment
throughout the NICU stay. The SNAP-II is more complex to calculate, rely-
ing on parameters such as PO2/FiO2, serum pH, presence of seizures, and urine
output. SNAPPE-II expands SNAP-II by adding gestational age, birthweight,
and Apgar score. The Berlin score includes similar complex variables to CRIB-II
and SNAPPE-II, including Apgar score, base excess, severity of respiratory dis-
tress syndrome, and use of artificial ventilation. Finally, NMPI utilises variables
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including PO2/FiO2, congenital malformations, base excess, and septicaemia.
Furthermore, these scores were all developed over 15 years ago. The most
recent score is CRIB-II, which was formulated in 2003. There have been signifi-
cant advancements in neonatal intensive care thereafter, and a recent extensive
review of the scoring systems has identified the need for updated and enhanced
scores based on more recent cohorts [31]. This is further highlighted by a recent
study [140], which found that the SNAPPE-II score achieved an AUROC of 0.849
on babies admitted to a Bangladesh hospital between 2012-2013. This is signif-
icantly lower than the AUROC of 0.91 that was reported in the 2001 paper in
which SNAPPE-II was proposed [179]. Similarly, a recent paper [178] conclude
that CRIB-II does not adequately account for advancements in neonatal care,
after finding that CRIB-II achieved AUROCs of 0.667 and 0.708 for mortality
cases in ≤7 days >7 days, respectively on babies admitted to the NICU of Sam-
sung Medical Centre between 2001-2011. This is undoubtedly a drastic decrease
from the AUROC of 0.92 reported in the 2003 paper that proposed CRIB-II
[134].
With recent studies identifying the weaknesses of existing scores, there has
some renewed interest in developing updated neonatal mortality risk scores using
new techniques, however this field is in its infancy when compared to the field of
adult mortality risk prediction. Several studies have done this using techniques
including logistic regression [141, 142], densely-connected neural networks [63],
random forest [143], and fusion of multiple machine learning algorithms into a
superlearner [62].
In one work [141], neonatal mortality risk prediction is considered for three
cases: pre-birth, at start of delivery, and 5 minutes post-birth. The latter was
the post-birth scenario, where variables used include mode of delivery, delivery
complications, size of baby, condition of the baby at 5 minutes, and several
more. Some of these variables are subjective, and were reported by mothers or
family members. Logistic regression with these parameters showed reasonably
good ability to distinguish between the mortality and non-mortality cases, as
measured by the area under the receiver-operator curve (AUROC) of 0.85.
Another work [142] analysed 18 candidate variables to develop a logistic re-
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gression model, ultimately selecting three parameters - birthweight, admission
oxygen saturation, and highest level of respiratory support within 24 hour of
birth. This relatively simple score achieved AUROCs of 0.8903 and 0.8082 on
UK and Gambian cohorts, respectively. The simplicity of these scheme is a large
advantage, however it focused only on babies who weighed less than 2000 g. Low
birthweight is defined by WHO as <2500 g, so this study exclusionary of some
babies who fall into this risk category.
Another recent work [143] considered multiple machine learning techniques,
namely logistic regression, linear and quadratic discriminant analysis, k-nearest
neighbor (KNN), support vector machine (SVM), random forest (RF), and three
Gaussian processes. The features selected incorporated vital signs, birthweight,
gestational age, and the SNAP-II and SNAPPE-II scores. The highest AUROC
of 0.922 was achieved using the random forest classifier. This shows strong
ability to distinguish between mortality and non-mortality cases, however the
dependence on SNAP-II and SNAPPE-II leads to a dependence on the complex
variables that these scores use.
Several machine learning techniques were also considered in another recent
work [63], including logistic regression, KNN, RF, Gradient Boosting Machine,
SVM, and densely-connected neural networks (NNs). Features used included
birthweight, gestational age, and other basic demographics, as well as more com-
plex variables such as presence of chorioamniotis, prenatal care, administration
of antenatal steroids, maternal hypertension, and more. The neural network
outperformed the other schemes, achieving an AUROC of 0.9136. This indicates
that NNs are a stronger candidate for solving the problem of neonatal mortality
than other machine learning techniques, however the complex variables used in
this work limit the usefulness of the scheme. Choosing simpler features would
greatly improve usability.
Another work [62] used a superlearner approach to predict mortality for post-
operative neonatal patients, creating a fusion of 14 machine learning techniques
to determine a best estimate. The algorithms included in the fusion were pre-
dominantly regression and RF algorithms. Extensive variables including demo-
graphics, existing conditions, prior treatments, congenital malformations, and
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incidence of sepsis were used. This work achieved an AUROC of 0.91, again
highlighting the strength of machine learning. However, the usefulness is once
again limited by complexity of variables. This particular work is also specifically
focused on postoperative neonates, rather than extending to all NICU patients.
The literature on predicting adult mortality is far more extensive, and many
studies have investigated machine learning for prediction of mortality in adult
ICU [35, 55–61], with most achieving reasonable ability to distinguish between
mortality and non-mortality. Of particular interest are long short-term memory
(LSTM) networks, which were identified to be suitable for mortality prediction
and the related problem of sepsis prediction in several works [46, 55, 61]. Ad-
ditionally, one work [57] identified that the hybridisation of LSTM networks
with convolutional neural networks (CNN) can enhance predictive performance,
although their own work was again based on complex variables.
A recurring limitation in the literature for both neonatal and adult mortality
prediction is the selection of variables that are tedious or difficult to measure
regularly. This limits the usefulness of such schemes, as often the acquisition of
these parameters would increase the burden on neonatal healthcare staff. Con-
versely, several other studies were limited by their selection of variables that do
not change - such as the scheme [142] that used birthweight, blood oxygen at
admission, and respiratory support within the first 24 hours from birth. This
prevents recalculation of the infant’s risk on a continuous or ongoing basis, and
does not allow for assessment of response to treatments.
An ideal mortality risk prediction scheme would be one that uses funda-
mental demographics and routinely measured parameters to provide continuous
mortality risk assessment, allowing for assessment of changing risk throughout
the NICU stay without placing unreasonable additional burden on NICU staff.
In this chapter, the Neonatal Artificial Intelligence Mortality Score (NAIMS)
is proposed. NAIMS is a hybrid CNN-LSTM neural network that relies on simple
demographics and trends in vital signs to determine mortality risk in the NICU
for short- and long-term risk windows. Using 12 hours of data from any window,
NAIMS shows strong performance in predicting an infant’s risk of mortality
within 3, 7, or 14 days. Due to the simplicity of the proposed scheme, NAIMS
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could readily be continuously and automatically recalculated, enabling analysis
of a NICU baby’s responsiveness to treatment and other health trends.
The remainder of this chapter is structured as follows: Section 6.2. presents
the methodology used for selecting, extracting, and processing data from an on-
line, open-source database. It also discusses the structure of the NAIMS network.
Section 6.3. includes results and discussion, including comparison to the afore-




The data used in this study was obtained from the Medical Information Mart
for Intensive Care (MIMIC-III) clinical database [151]. This database includes
records from 7870 neonates admitted between 2001-2008. As this study focuses
on all infants admitted to the NICU for any reason, the criterion used to select
patients was that the first care unit was the NICU. No exclusions were made
based on birthweight, gestational age, or other factors.
At this stage, length of stay for the mortality cases was evaluated to determine
the most useful windows for mortality prediction. It was found that the average
length of stay (LOS) was 8.08 days with a high standard deviation (SD) of
16.75 days. This served as the motivation for considering several risk windows
of varying lengths, namely 3-day, 7-day, and 14-day windows. Assessment of
mortality risk within these three windows would enable assessment of immediate
risk, as well as longer-term survival prospects.
Given the largest window of interest is 14 days, there were 14 days of data
acquired for each patient. If the NICU stay exceeded 14 days, the first 14 days
were obtained for non-mortality cases, while the 14 days prior to death time were
used for the mortality cases. Where any patient stay was less than 14 days, all
data from NICU admission to discharge or death were obtained.
Information obtained from this database included gestational age, birth-
weight, gender, time of death (where applicable) and available chart events.
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Feature selection was then performed, as discussed in the following subsection.
6.2.2 Feature Selection
In selecting features for the proposed NAIMS scheme, there were several major
considerations. Firstly, to prevent placing additional burden on healthcare staff,
it was determined that features must be based on parameters that are easy
to measure. Ideally, dynamic parameters would also be able to be measured
automatically. Secondly, feature selection was supported by recent findings in
the literature.
Demographics features that describe fundamental information about the pa-
tient were selected - namely birthweight, gestational age, and gender. Birth-
weight and gestational age have repeatedly been shown in the literature to be
strong indicators of mortality risk, and have been used by most existing schemes
in the literature for this reason. Birthweight is a static variable, and thus the
first birthweight in the patient’s record was used. For most patients, gestational
age was recorded in MIMIC-III as a range (i.e. 26-28) weeks. As such, took the
middle value of the provided range was taken to be the gestational age. Where
the infant was older than 40 weeks, their gestational age was recorded as “40” in
MIMIC-III; thus any patients in this age group had their gestational age recorded
as simply 40.
Sex has also been used as it has been long known that physiological differences
between the genders lead to differing normal ranges for vital signs [180]. During
preprocessing, the sex of babies was set to either ‘1’ or ‘0’, corresponding to the
‘F’ or ‘M’ classification in MIMIC-III, respectively.
Next, features were selected from commonly recorded parameters in the
NICU. A recent comprehensive review paper [181] concluded that the current
techniques of intermittent vital sign measurement fail to capture health trends,
and that continuous analysis of vital sign trends would likely improve outcomes
for NICU patients. Another work [182] identified that short-term variability of
heart rate (HR) and respiratory rate (RR) are strong predictors of high morbid-
ity. As such, focus was placed on HR and RR in this work. These two metrics are
readily available in the MIMIC-III database, indicating that they are currently
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recorded routinely and readily in NICU environments.
To capture information about the trends in these two vital signs, a 12-hour
period at the beginning of the relevant risk window was selected. All HRs and
RRs during this 12-hour window were recorded, and then statistical analysis was
applied to quantify the variation of each vital sign during the 12-hour window.
For both HR and RR, the first value, last value, minimum value, maximum
value, mean value, median value, and standard deviation was calculated for in-
clusion in the feature vector. The first and last values were chosen as these can
highlight major changes in the vital sign during the 12-hour window. Minimum
and maximum are used to show the most extreme values during the consid-
ered window. To represent the average vital sign, both mean and median were
recorded. While mean is typically more useful, median is helpful in the case
where there are significant outliers. Finally, the standard deviation is used as it
is a strong indicator of variability. Where either HR or RR measurements were
completely absent from a patient’s record, that record was discarded and not
used for training or testing.
The final feature array was as follows: birthweight, gestational age, gender,
first value for HR, last value for HR, minimum HR, maximum HR, mean HR,
median HR, standard deviation of HR, first value for RR, last value for RR,
minimum RR, maximum RR, mean RR, median RR, and standard deviation of
RR.
These features were calculated from the first 12 hours for each of the con-
sidered risk windows; 3-day, 7-day, and 14-day. Cohorts varied in size for each
considered risk window, due to differing levels of missingness in the data for
different windows.
6.2.3 Balancing the Dataset
Following data and feature selection, it was clear that the data was strongly
unbalanced. In the cohort that met all criteria for inclusion in training and test-
ing the 3-day NAIMS scheme, only 1.02% of the 2,751 cases ended in mortality.
Similarly, for 7-day and 14-day NAIMS, the mortality rates were 1.02% of 2,751
cases and 1.09% of 2,753 cases, respectively. The level of imbalance can cre-
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ate significant overfitting issues when training a neural network, and as such the
non-mortality cases were undersampled by saving only 150 eligible non-mortality
records.
Following undersampling, the mortality rate in the 3-day and 7-day cohorts
was 15.64% of 179 cases, while for 14-day NAIMS the mortality rate was 16.47%
of 181 cases. Further statistical analysis of the cohorts used for training and
testing each version are outlined in Tables 6.1 and 6.2 below, with 3-day, 7-
day, and 14-day names hereafter denoted as NAIMS-3, NAIMS-7 and NAIMS-14
respectively.







Birthweight (kg) 2.13 (0.46-4.76) 2.27 (0.61-4.76) 1.39 (0.46-3.64)
Female 77 (43.02%) 71 (47.02%) 6 (21.43%)
Gestational age at
birth (weeks)
≤24 16 (8.94%) 5 (3.31%) 11 (39.29%)
25-28 22 (12.29%) 14 (9.27%) 8 (28.57%)
29-32 15 (8.38%) 13 (8.61%) 2 (7.14%)
33-36 87 (48.60%) 85 (56.29%) 2 (7.14%)
≥40 39 (21.79% 34 (22.52%) 5 (17.86%)







Birthweight (kg) 2.12 (0.46-4.76) 2.27 (0.61-4.76) 1.37 (0.46-3.64)
Female 79 (43.65%) 71 (47.02%) 8 (26.67%)
Gestational age at
birth (weeks)
≤24 16 (8.84%) 5 (3.31%) 11 (36.67%)
25-28 24 (13.26%) 14 (9.27%) 10 (35.72%)
29-32 15 (8.29%) 13 (8.61%) 2 (6.67%)
33-36 87 (48.07%) 85 (56.29%) 2 (6.67%)
≥40 39 (21.55% 34 (22.52%) 5 (6.67%)
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6.2.4 Neural Network Structure
Hybrid networks have previously been used in mortality prediction for adults
in one work that used extensive laboratory values and vital signs over a 48-
hour window, achieving reasonable AUROC of 0.834 [57]. While this shows good
ability to distinguish between mortality and non-mortality cases, the dependence
on long measurement windows and laboratory measurements limits the usability
of the scheme for adult patients, let alone neonatal patients.
Figure 6.1: Neural network structure for NAIMS.
As such, in this chapter a shallow CNN-LSTM hybrid neural network is pro-
posed, as illustrated in Fig. 6.1. The hybridisation of these two NN types
combines the benefits of both. CNNs are well known for their ability to iden-
tify important features, while LSTM networks are well known for their ability
to remember previous data in the sequence. These attributes are important
in health applications, where the most important features are often not known.
Deeper networks were trialled, however no improvement in performance was seen
as a result of adding further layers. As such, the shallow network was used for
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maximum efficiency.
The proposed NAIMS network uses the 17-feature vector outlined in the
previous subsection as the input. This input vector is passed to the first layer, a







i ∗ xm(i-1) + bji). (6.1)
where yij is the jth output feature map from the ith layer. The term wjn
i,
denotes the nth weight of the jth output feature map from the (i − 1)th layer,
with n = 1, ..., N . The bias term bj is the jth bias term of the ith layer. Weights
and biases are updated during training using the Adam optimization algorithm.
The outputs of the (i − 1)th layer are denoted as xm(i-1) represents the outputs
of the (i− 1)th layer. Finally, the convolution operation itself is denoted by the
asterisk symbol (∗).
The temporal CNN layer is then followed by a temporal average pooling layer,
with pool and stride sizes of 2. This operation steps through the output of the
CNN layer and takes the average of each pool. This results in a undersampled
output, which aids in prevention of overfitting without needing to use dropout.
The output from the pooling layer is then passed to a bidirectional LSTM
(BiLSTM) layer with 128 hidden units. The mathematical structure of the layer
is shown in Eqs. (6.2)-(6.7). As the layer is bidirectional, the data is passed
through this mathematical process in both original and reversed orders. The
benefit of bidirectionality is that the layer can learn from both past and future
values in the sequence.
c̃t = tanh(wc[ a(t-1), xt] + bc) (6.2)
f t = σ(wf[ a(t-1), xt] + bf) (6.3)
ut = σ(wu[ a(t-1), xt] + bu) (6.4)
ot = σ(wo[ a(t-1), xt] + bo) (6.5)
ct = ut • c̃t + f t • c(t-1) (6.6)
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at = ot • tanh(ct) (6.7)
where weights are indicated by wc, wf, wu and wo, respectively. Biases are
indicated by bc, bf, bu and bo, respectively. Again, biases and weights are up-
dated using the Adam optimization algorithm. Outputs of the previous layer are
denoted as a(t-1), while xt is the input to time t. Equations 6.6 and 6.7 are the
updated cell state and layer output respectively. Element-wise multiplication is
denoted by ‘•’, while σ is the sigmoid activation function.
The final layer of NAIMS is a densely-connected node utilizing signmoid
activation. Where the result of this activation is ≥ 0.5, the patient is predicted
to die within the 3-day, 7-day, or 14-day window of the respective networks.
Conversely, a result < 0.5 indicates survival for that period.
6.2.5 Training & Testing the Algorithms
The NAIMS network was trained using stratified k-fold cross-validation with 5
folds, a method that splits data in 5 different ways while ensuring consistent
ratios of the positive to negative cases in each split. All data is used as part of
the testing set in only one of the five folds. Results obtained via cross-validation
provide a more realistic view of the network performance. Due to using five folds
for cross-validation, 20% of the data was used for testing in each fold, and thus
remained unseen to the network while training for that fold. For training and
validation, 60% and 20% of the data was used, respectively.
Even after undersampling the non-mortality cases, the remaining data was
unbalanced, with mortality occurring in up to 16.47% of cases. To prevent over-
fitting to the majority case of non-mortality, heavier weightings were placed on
the importance of learning the mortality case until their relative importances
were roughly equivalent. This ensured that the network would consider accurate
prediction of the death and survival cases as equally important, which is essential
to prevent overfitting to either case.
For each of the five folds, NAIMS was trained for 75 epochs with a batch size
of 2048 with binary cross-entropy used as the loss function. This combination
was found to enable good generalization. During each fold, the weights that
resulted in the lowest validation loss were used for testing.
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6.3 Results & Discussions
In analysing the performance of the NAIMS networks, the key metric consid-
ered was area under the receiver-operator curve (AUROC). AUROC is the most
common metric used for analysing diagnostics tools, and is calculated from the
receiver-operator curve (ROC). Higher AUROC values indicate stronger ability
to distinguish between the mortality and non-mortality case. Fig. 6.1 plots the
ROC curves for NAIMS-3, NAIMS-7 and NAIMS-14, with the AUROC shown in
the legend. From this graph, it is clear that NAIMS-3 has achieved the highest
AUROC, followed by NAIMS-7 and then NAIMS-14.
Figure 6.2: Comparison of ROCs for all NAIMS schemes.
Area under the precision-recall curve (AUPRC) is also often considered, par-
ticularly where data is imbalanced and the predictive performance on the positive
cases is highly important. AUPRC is considered with respect to the performance
of a baseline random classifier, which would vary in performance depending upon
the imbalance of the data. The higher the AUPRC is above the random classifier,
the better its ability to distinguish between the two classes. The precision-recall
curves for all NAIMS schemes are shown in Fig. 6.3, with AUPRC values pre-
sented in the legend. This figure clearly shows that the AUPRC for NAIMS-3 is
very strong, with NAIMS-7 and NAIMS-14 also performing quite strongly. Over-
all, this indicates that all three models are distingushing well between mortality
and non-mortality cases.
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Figure 6.3: Comparison of PRCs for all NAIMS schemes.
The results obtained by NAIMS-3, NAIMS-7 and NAIMS-14 during the test-
ing phase are further numerically summarised in Table 6.3. In addition to
AUROC and AUPRC, several metrics were considered to evalutate the predic-
tive accuracy. Overall accuracy (ACC), sensitivity or true positive rate (TPR),
and specificity or true negative rate (TNR) were calculated for each version of
NAIMS. TPR and TNR are useful metrics for an unbalanced data set, as they
show the accuracy for the positive (mortality) and negative (survival) cases, re-
spectively. This allows for analysis of the fit; if ACC, TPR and TNR are all
similar values, then the network has fit equally well to both cases despite the
imbalance of the data.
Table 6.3: Results obtains by NAIMS, presented as the average across the 5 folds with
standard deviation in parantheses.
Scheme ACC (%) TPR TNR AUROC AUPRC
NAIMS-3 86.81 0.8710 0.8675 0.9336 0.8397
(7.88) (0.0726) (0.0941) (0.0337) (0.0356)
NAIMS-7 80.33 0.8125 0.8013 0.8804 0.7207
(5.74) (0.0568) (0.0787) (0.0471) (0.1511)
NAIMS-14 73.77 0.7500 0.7351 0.8470 0.6904
(6.09) (0.0916) (0.0894) (0.0259) (0.0824)
As shown in Table 6.3, NAIMS-3 performed extremely strongly. NAIMS-3
achieved an excellent AUROC of 0.9336 with strong overall accuracy and highly
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similar performance on both the positive and negative classes, as shown by the
TPR and TNR values. Both NAIMS-7 and NAIMS-14 also achieved good results,
with strong AUROC values and reasonable accuracy. Unsurprisingly, NAIMS-3
was the strongest performer across all metrics. This is likely due to it’s shorter
predictive window, as the patient is more likely to be showing signs of deteriora-
tion when mortality risk is assessed for a shorter window. Meanwhile NAIMS-14
had the lowest performance, likely due to the longer window. This trend further
emphasises the need for continuous short-term mortality risk assessment as an
alternative or compliment to the single mortality assessment that is routinely
performed at admission time in NICUs today.
It is also worth noting that the models could readily be tuned to focus more
heavily on predicting the positive case, however this would lead to reduced predic-
tive performance for the negative case and thus an increase in false alarms. This
work aimed for roughly equal ability to predict both the positive and negative
case with the intention of reducing alarm fatigue, a well documented phenomenon
in NICU and general hospital environments [183–185] wherein healthcare workers
are overwhelmed by the large number of patient health alarms and thus become
desensitized to them. Alarm fatigue leads to serious risk of missing significant
alarms, which has previously lead to deaths in hospitals [184].
6.3.1 Comparison to Previous Works
In this section, the results achieved by the NAIMS schemes are compared to works
presented in the literature. Table 6.4 compares the AUROCs of recent works,
and includes descriptions of the features and measurement windows considered
in each of the included works. The majority of previous works did not include
ACC, TPR, TNR and/or AUPRC values in their analyses, so these have been
excluded from the table.
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The results presented in Table 6.4 indicate that NAIMS-3 outperforms all
previous works in the literature, achieving a significantly higher AUROC than all
previous works. This high-performing network also has several other advantages
over existing schemes, including the ability to perform mortality risk assessment
based on any 12-hour window of data during the patient’s stay.
NAIMS-7 performs comparably to previous works, outperforming multiple
schemes. NAIMS-14 performs comparably to the work presented by Houweling,
et al. [141], however does not perform as strongly as much of the literature. It
is likely that access to additional training data would improve the performance
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of all NAIMS networks, and indeed this would be the next step required to work
towards implementation of these schemes in real healthcare environments.
While the proposed NAIMS networks depend upon more features than some
previous works, 14 of the 17 features are easily derived from temporal HR and
RR data. Conversely, several works [63, 141] depend on variables that are com-
pletely distinct from each other and thus require more extensive acquisition and
calculation. Furthermore, the work presented by Houweling, et al. [141] de-
pends upon subjective metrics assessing the baby’s appearance, rather than on
tangiable measurements. In the work presented by Jaskari, et al. [143] only
14 variables are directly mentioned, however the dependence on SNAP-II and
SNAPPE-II introduce many additional dependencies. Of the previous works in-
cluded in Table 6.4, only the scheme presented by Jaskari, et al. [143] could be
updated on an ongoing basis during the patient stay. All other works depend on
variables that are static and are measured immediately post-birth.
Another significant advantage of all NAIMS schemes is the ability to be up-
dated regularly and automatically, which allows for easier identification of trends
in the patient’s health. Gender and birthweight are fixed at birth, and gestational
age could be automatically updated as the baby ages. HR and RR statistical val-
ues can be automatically calculated from monitoring equipment, or from manual
data entries made by healthcare staff. Meanwhile, the only other scheme in the
literature that is designed in such a way that mortality risk could be updated dur-
ing the stay [143] still depends upon variables that would realistically make this
challenging. Namely, it depends upon SNAP-II and SNAPPE-II scores which in-
troduce a direct dependency on parameters such as PO2/FiO2, base excess, and
urine output. Such parameters are substantially more complex to measure than
vital signs, and thus would introduce a higher burden on healthcare workers.
Overall, the NAIMS schemes perform well when compared to existing schemes
in the literature. In particular, NAIMS-3 outperforms all works in the literature,
highlighting the benefit of shorter-term mortality risk assessment. NAIMS can
be recalculated regularly and automatically, allowing for ongoing analysis of the
patient’s condition during the NICU stay. Furthermore, NAIMS uses a short,
12-hour window of temporal data to make its predictions, allowing the first pre-
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diction to be made within half a day of admission, without needing knowledge
of maternal condition prior to birth. As a result of these benefits and the strong
ability to distinguish between mortality and non-mortality cases, it is suggested
that the NAIMS schemes are suitable for use in predicting mortality risk in
NICU environments. In particular, the NAIMS-3 scheme outperforms all ex-
isting works in the literature and would thus be highly suitable for use as a
continuously-updating short-term mortality risk prediction tool.
6.4 Conclusion
In this chapter, the NAIMS shallow hybrid neural network is proposed, utilizing
temporal convolution, pooling, and long short-term memory layers. NAIMS was
then trained and tested for predicting mortality risk within the following 3, 7, and
14 day periods, resulting in NAIMS-3, NAIMS-7, and NAIMS-14, respectively.
It was shown that NAIMS-3 outperformed all other schemes in the literature,
with NAIMS-7 and NAIMS-14 performing comparably to several state-of-the-art
works. The high performance of NAIMS-3 indicates that this network would be
suitable for use in NICU environments.
NAIMS also depends only upon simple features that are readily available in
the NICU environment already. This simplicity enables regular and automatic
recalculation of mortality risk during the stay, which in turn enables healthcare
workers to monitor a patient’s health trends and response to any treatments.
The primary limitation of this work was the low availability of data. While
MIMIC-III contains extensive records for adult patients, relatively few neonatal
patients were included. Furthermore, the mortality rate amongst NICU patients
in MIMIC-III was 1.02%, resulting in a need to undersample the non-mortality
cases to prevent overfitting in training. Nonetheless, this work serves as a proof-
of-concept that neonatal mortality risk can be predicted from easily obtained
vital signs in the NICU.
Overall, the NAIMS scheme performs strongly in mortality prediction for
shorter risk windows. The presented results indicate that NAIMS-3 outper-
forms previous works in the literature, while NAIMS-7 and NAIMS-14 perform
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comparably. The NAIMS schemes could readily be implemented in healthcare
environments due to the high availability of the vital sign data it depends on in
healthcare environments. Further clinical testing would be required to validate
the performance of the network before widespread implementation could occur.
This chapter and the NAIMS scheme address the research problem of mor-
tality risk assessment in a neonatal cohort, as discussed in Section 1.2.3. It also
provides the fifth and final original contribution of this thesis. This chapter has
further validated that vital sign information can be used to assess mortality risk
across multiple critical care cohorts. It has also reiterated the strong performance





Patient outcomes in intensive care units can be vastly improved through contin-
uous and non-invasive monitoring of vital signs and quantification of mortality
risk. Existing algorithms in the literature for monitoring the vital signs of blood
pressure and respiratory rates are unsuitable for clinical implementation, while
existing schemes for determining patient risk are dependent on many complex
health metrics that are challenging to recalculate throughout a patient’s hospi-
tal stay. This thesis addresses these issues through the development of machine
learning schemes for the measurement of blood pressure and respiratory rate
from heart activity waveforms, before moving on to the assessment of mortality
risk using vital sign data and basic demographics.
The research problem presented in Section 1.2.1 is addressed through the de-
velopment of two schemes for non-invasive and continuous blood pressure mea-
surement. Firstly, a hybrid CNN-LSTM neural network was developed for the
calculation of SBP, DBP, and MAP using five-second segments of ECG and PPG
waveforms as inputs. This minimised preprocessing and reduced the risk of intro-
ducing human bias to the neural network. The proposed scheme outperforms all
other schemes in the literature, and meets the standards set by both the AAMI
and BHS. Based on the results presented in this chapter, it is highly likely that
this scheme would be suitable for clinical use.
Next, this work expands upon the investigation of suitable blood pressure
monitoring techniques to develop a more computationally efficient alternative.
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Twelve simple features that describe the structure of the ECG and PPG wave-
forms are extracted and used as features, minimising the risk of human bias im-
pacting the learning of the neural network while improving efficiency. A shallow
CNN-LSTM network was then used to predict SBP, DBP, and MAP. The per-
formance of this scheme was slightly lower than that of the scheme presented in
the previous chapter, however still performed strongly compared to the literature
and comfortably met the AAMI and BHS standards for blood pressure devices.
This scheme would serve as a suitable alternative in low-powered devices.
The second research problem, presented in Section 1.2.2, was considered
next. A scheme was developed to measure respiratory rate continuously and
non-invasively, with ECG and PPG signals again used to derive inputs. Respi-
ratory rate modulates these heart activity signals in three ways, and thus each
modulation was extracted from both signals. A respiratory quality index (RQI)
tool was then used to quantify the quality of the extracted modulation waveform
and a candidate respiratory rate was derived. Where the six candidate RRs and
corresponding RQIs were used as inputs to a bidirectional LSTM neural network,
the results outperformed all previous works. It was found that the inclusion of
the proposed RQI scheme greatly enhanced the neural network’s ability to learn
from the data. Overall, the results of this chapter indicate that this scheme could
be implemented in clinical environments.
This concluded investigations of enhanced vital sign monitoring. The pro-
posed schemes for blood pressure and respiratory rate fill a significant gap in
the literature; of the five vital signs, only respiratory rate and blood pressure
were previously unable to be monitored continuously and non-invasively. The
schemes presented in this thesis also depend only upon waveforms that are al-
ready recorded in hospitals. The ability to measure all five vital signs continu-
ously has significant diagnostic benefit to environments such as intensive care,
leading to the second theme of this thesis - mortality risk assessment in intensive
care. This research problem was described in Section 1.2.3, with consideration
of both adult and neonatal cohorts.
Mortality risk prediction for adult patients was considered first, with varia-
tions in vital signs over a 24-hour period quantified with straightforward statis-
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tics and used as inputs to a CNN-LSTM hybrid neural network model. The
model was trained to predict mortality risk within 3-day, 7-day and 14-day pe-
riods, enabling quantification of mortality risk within several risk windows. The
proposed model performed strongly compared to the literature, indicating that
vital signs offer viable metrics for the accurate prediction of mortality in criti-
cal care settings. The simplicity of the features ensures that mortality risk can
be continuously updated throughout the stay, providing invaluable information
about whether a patient is responding to treatment or not, thus allowing medical
professionals to modify their treatment plan more readily.
Following the success of the adult mortality risk prediction scheme, neonatal
mortality risk assessment was considered using a similar approach. A shallow
CNN-LSTM neural network was developed and trained using information re-
garding the variation of heart rate and respiratory rate within a 12-hour period,
with the scheme for predicting mortality over a 3-day window outperforming all
existing works in the literature. The scheme also performed strongly when quan-
tifying 7-day and 14-day mortality risk. This further indicates that vital signs are
suitable candidates for mortality prediction, and that short-term mortality risk
prediction is more suitable than existing schemes based on whole-stay mortality
risk assessment at time of admission.
This concluded the investigation on mortality risk assessment, filling a sig-
nificant gap in the literature by devising first-of-a-kind schemes for continuously
updating mortality risk prediction that relies only on vital sign features. Pre-
vious schemes in the literature were non-continuous and depended on complex
laboratory testing, limiting their usefulness in the real world.
Overall, this thesis has addressed the research problems outlined in Section
1.2 through developing enhanced methods for non-invasive measurement of blood
pressure and respiratory rate, enabling all five vital signs to now be measured
continuously. This thesis then investigated the use of vital signs for prognos-
tic purposes, namely quantifying the severity of illness in critical care patients
through mortality risk assessment. With the implementation of the proposed
techniques for measuring vital signs, the mortality risk prediction schemes would
become increasingly powerful.
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The significance of this work lies in the development of tools that address key
needs in the medical industry. Vital signs are key indicators of overall health,
and this work presents novel and accurate methods for measuring these parame-
ters non-invasively and continuously from sensors which are readily available in
clinical settings and wearable devices. The importance of measuring vital signs
accurately and continuously is further emphasised by the successful development
of prognostics tools for mortality risk assessment presented in this thesis. The
mortality risk prediction schemes are also significant in the healthcare field. The
schemes proposed in this work require little to no manual input from health-
care workers, minimizing time wasted on data entry and analysis. They also
would improve patient experience, as it eliminates the dependency on extensive
laboratory tests that is present in existing schemes. Overall, this work has sig-
nificant implications for device manufacturers, healthcare staff, and end-users in
applications ranging from at-home fitness tracking to critical care units.
7.1.1 Recommendations for Future Work
Healthcare is a broad field, and while this thesis has addressed many key gaps in
the literature, there are certainly still opportunities for future work. Suggested
areas for future directions include:
• Clinical trials for the developed algorithms - the blood pressure and respi-
ratory rate measurement techniques presented in this thesis are dependent
on ECG and PPG, both of which are readily available in hospital settings.
Conducting clinical trials in hospital settings is a vital but significant task
in moving towards real-world implementation of the proposed algorithms.
• Development of wearable hardware devices - the development and testing of
highly wearable devices implementing ECG and PPG sensors would enable
the use of these algorithms in applications ranging from fitness tracking
to telehealth, and would enable continuous health monitoring outside of
hospital settings.
• Investigation of multiple PPG as a replacement for ECG and PPG - while
ECG is acquirable via wearables, it is more challenging to do so contin-
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uously than it is to measure PPG waveforms continuously. Therefore it
would be worthwhile exploring whether multiple PPG signals, perhaps ac-
quired from different locations on the body, could be used to achieve com-
parable performance to the current combination of ECG and PPG. This
would require extensive hardware design and data acquisition.
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